RuangJurnal.com – Memilikki layanan jasa pembuatan jurnal scopus meliputi pembuatan jurnal internasional, konversi, perbaikan kualitas paper dan publikasi yang terdiri dari Prosiding Internasional ISSN, Jurnal Internasional ISSN (Index Copernicus, DOAJ dll), Jurnal Scopus Q4, Jurnal Scopus Q3, Jurnal Scopus Q2, Jurnal Scopus Q1.
Ruang Jurnal telah mengumpulkan jurnal sjr scopus dengan scope Medicine New Zealand. Bagi Anda yang membutuhkan referensi jurnal Indonesia yang telah terindeks scopus dapat menggunakannya sebagai bahan bacaan dan sumber referensi penelitian. Untuk menyimpan laman ini melalui laptop/pc dengan CTRL + D atau masuk menu setting (garis tiga pojok atas) pilih bookmark pada smartphone.
[lwptoc title=”Daftar Jurnal SJR Scopus Medicine New Zealand – Jasa Jurnal Scopus”]
Daftar Jurnal Index Scopus Medicine 2020
| Title | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) |
| Clinical Epidemiology | 1.868 Q1 | 58 | 139 | 329 | 4946 | 1438 | 315 | 4.24 | 35.58 |
| Journal of Inflammation Research | 1.656 Q1 | 33 | 109 | 98 | 6117 | 595 | 96 | 6.53 | 56.12 |
| Palliative Care | 1.514 Q1 | 7 | 0 | 14 | 0 | 60 | 14 | 0.5 | 0 |
| Lung Cancer: Targets and Therapy | 1.433 Q1 | 16 | 11 | 55 | 594 | 238 | 55 | 4.07 | 54 |
| International Journal of COPD | 1.394 Q1 | 67 | 319 | 1042 | 12559 | 3357 | 1003 | 2.94 | 39.37 |
| International Journal of Nanomedicine | 1.245 Q1 | 128 | 681 | 1919 | 40894 | 12698 | 1913 | 5.93 | 60.05 |
| Breast Cancer: Targets and Therapy | 1.190 Q2 | 27 | 27 | 115 | 1276 | 527 | 113 | 4.96 | 47.26 |
| Clinical Interventions in Aging | 1.184 Q1 | 76 | 233 | 716 | 9978 | 3141 | 695 | 4.16 | 42.82 |
| Journal of Asthma and Allergy | 1.162 Q1 | 30 | 76 | 101 | 3379 | 424 | 99 | 4.45 | 44.46 |
| International Journal of Women’s Health | 1.136 Q1 | 45 | 131 | 251 | 5192 | 845 | 248 | 2.52 | 39.63 |
| Clinical and Experimental Gastroenterology | 1.113 Q2 | 30 | 56 | 119 | 2722 | 425 | 118 | 3.53 | 48.61 |
| Biomarker Insights | 1.075 Q1 | 31 | 17 | 59 | 1317 | 270 | 58 | 5.5 | 77.47 |
| Psoriasis: Targets and Therapy | 1.066 Q1 | 4 | 0 | 1 | 0 | 4 | 1 | 0 | 0 |
| OncoTargets and Therapy | 1.054 Q2 | 60 | 1122 | 2479 | 45214 | 9545 | 2472 | 3.85 | 40.3 |
| Infection and Drug Resistance | 1.033 Q2 | 39 | 463 | 707 | 20129 | 2850 | 690 | 3.84 | 43.48 |
| Substance Abuse: Research and Treatment | 1.027 Q2 | 22 | 41 | 71 | 2135 | 201 | 63 | 2.52 | 52.07 |
| Clinical Ophthalmology | 1.025 Q2 | 56 | 499 | 919 | 16440 | 2157 | 890 | 2.14 | 32.95 |
| Cancer Management and Research | 1.024 Q2 | 40 | 1211 | 1655 | 44445 | 5999 | 1650 | 3.64 | 36.7 |
| Eye and Brain | 1.017 Q2 | 15 | 14 | 18 | 954 | 71 | 18 | 3.93 | 68.14 |
| Biologics: Targets and Therapy | 0.948 Q2 | 38 | 12 | 49 | 833 | 178 | 49 | 4.11 | 69.42 |
| Integrative Medicine Insights | 0.933 Q1 | 12 | 0 | 4 | 0 | 28 | 4 | 12 | 0 |
| Vascular Health and Risk Management | 0.892 Q2 | 68 | 60 | 146 | 2459 | 495 | 146 | 3.57 | 40.98 |
| Journal of Pain Research | 0.888 Q1 | 49 | 349 | 959 | 14053 | 2843 | 930 | 2.76 | 40.27 |
| Patient Preference and Adherence | 0.885 Q1 | 48 | 232 | 681 | 9520 | 1934 | 672 | 2.54 | 41.03 |
| Application of Clinical Genetics | 0.879 Q3 | 32 | 20 | 61 | 1014 | 156 | 59 | 1.78 | 50.7 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 0.853 Q2 | 43 | 476 | 391 | 21445 | 1234 | 382 | 2.91 | 45.05 |
| International Journal of Nephrology and Renovascular Disease | 0.846 Q2 | 27 | 41 | 95 | 1820 | 275 | 95 | 2.85 | 44.39 |
| Risk Management and Healthcare Policy | 0.828 Q2 | 22 | 316 | 81 | 12502 | 261 | 78 | 2.8 | 39.56 |
| Neuropsychiatric Disease and Treatment | 0.819 Q2 | 67 | 307 | 1032 | 14840 | 2643 | 1008 | 2.4 | 48.34 |
| Virology: Research and Treatment | 0.765 Q2 | 10 | 0 | 12 | 0 | 37 | 11 | 1.8 | 0 |
| HIV/AIDS – Research and Palliative Care | 0.752 Q2 | 22 | 96 | 92 | 3543 | 207 | 89 | 1.93 | 36.91 |
| Breast Cancer: Basic and Clinical Research | 0.741 Q3 | 23 | 37 | 56 | 1672 | 123 | 55 | 1.95 | 45.19 |
| Clinical, Cosmetic and Investigational Dermatology | 0.730 Q2 | 35 | 113 | 239 | 4522 | 665 | 235 | 2.34 | 40.02 |
| International Journal of General Medicine | 0.722 Q2 | 36 | 194 | 174 | 6690 | 441 | 169 | 2.45 | 34.48 |
| Therapeutics and Clinical Risk Management | 0.719 Q2 | 55 | 127 | 607 | 5947 | 1443 | 600 | 2.28 | 46.83 |
| Orthopedic Research and Reviews | 0.707 Q2 | 9 | 24 | 44 | 834 | 105 | 44 | 2.55 | 34.75 |
| Psychology Research and Behavior Management | 0.704 Q2 | 30 | 125 | 201 | 6068 | 613 | 197 | 2.85 | 48.54 |
| Clinical Pharmacology: Advances and Applications | 0.685 Q2 | 27 | 28 | 53 | 926 | 158 | 53 | 2.85 | 33.07 |
| Local and Regional Anesthesia | 0.679 Q2 | 17 | 26 | 53 | 1098 | 119 | 48 | 2.43 | 42.23 |
| Journal of Blood Medicine | 0.676 Q3 | 18 | 56 | 104 | 2231 | 249 | 102 | 2.2 | 39.84 |
| Integrated Blood Pressure Control | 0.652 Q2 | 20 | 18 | 21 | 842 | 57 | 21 | 2.93 | 46.78 |
| Journal of Multidisciplinary Healthcare | 0.650 Q2 | 30 | 203 | 221 | 7804 | 571 | 218 | 2.31 | 38.44 |
| Clinical Medicine Insights: Cardiology | 0.634 Q2 | 21 | 21 | 60 | 921 | 154 | 58 | 2.5 | 43.86 |
| Open Access Rheumatology: Research and Reviews | 0.630 Q3 | 14 | 41 | 79 | 1429 | 182 | 79 | 2.02 | 34.85 |
| Cancer Informatics | 0.606 Q3 | 31 | 17 | 89 | 563 | 169 | 83 | 2.06 | 33.12 |
| Stem Cells and Cloning: Advances and Applications | 0.606 Q2 | 22 | 10 | 18 | 591 | 57 | 18 | 2.6 | 59.1 |
| Clinical Medicine Insights: Oncology | 0.601 Q3 | 26 | 20 | 51 | 736 | 114 | 51 | 2.06 | 36.8 |
| ClinicoEconomics and Outcomes Research | 0.591 Q2 | 27 | 68 | 218 | 2670 | 406 | 216 | 1.68 | 39.26 |
| Journal of Experimental Pharmacology | 0.555 Q3 | 12 | 55 | 34 | 3286 | 113 | 34 | 2.24 | 59.75 |
| Drug, Healthcare and Patient Safety | 0.530 Q2 | 24 | 32 | 37 | 992 | 70 | 37 | 1.42 | 31 |
| Research and Reports in Urology | 0.506 Q2 | 20 | 79 | 108 | 2768 | 192 | 107 | 1.64 | 35.04 |
| Medical Devices: Evidence and Research | 0.482 Q3 | 30 | 40 | 122 | 1649 | 263 | 116 | 1.59 | 41.23 |
| New Zealand Medical Journal | 0.462 Q3 | 50 | 298 | 787 | 1794 | 597 | 489 | 0.71 | 6.02 |
| Virus Adaptation and Treatment | 0.459 Q3 | 9 | 0 | 6 | 0 | 11 | 6 | 1.5 | 0 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.429 Q3 | 17 | 20 | 25 | 729 | 29 | 25 | 1.1 | 36.45 |
| Clinical Optometry | 0.421 Q3 | 7 | 28 | 57 | 900 | 76 | 53 | 1.38 | 32.14 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.418 Q3 | 21 | 16 | 53 | 581 | 82 | 52 | 1.14 | 36.31 |
| Open Access Emergency Medicine | 0.408 Q2 | 14 | 56 | 79 | 1842 | 119 | 78 | 1.43 | 32.89 |
| Clinical Medicine Insights: Blood Disorders | 0.405 Q3 | 10 | 4 | 22 | 144 | 47 | 22 | 3.25 | 36 |
| Clinical Medicine Insights: Gastroenterology | 0.373 Q3 | 11 | 0 | 27 | 0 | 37 | 27 | 1.71 | 0 |
| Drug Target Insights | 0.297 Q3 | 12 | 0 | 10 | 0 | 20 | 9 | 2 | 0 |
| ImmunoTargets and Therapy | 0.256 Q4 | 7 | 0 | 1 | 0 | 2 | 1 | 0 | 0 |
| Fluoride – Quarterly Reports | 0.254 Q4 | 46 | 26 | 128 | 959 | 138 | 116 | 1.02 | 36.88 |
| Open Access Journal of Clinical Trials | 0.223 Q3 | 12 | 6 | 17 | 207 | 11 | 17 | 0.44 | 34.5 |
| Clinical Medicine Insights: Therapeutics | 0.205 Q4 | 9 | 0 | 28 | 0 | 18 | 28 | 0.75 | 0 |
| Translational Oncogenomics | 0.205 Q4 | 10 | 0 | 1 | 0 | 2 | 1 | 0 | 0 |
| Transplant Research and Risk Management | 0.205 Q4 | 6 | 5 | 16 | 110 | 10 | 15 | 0.44 | 22 |
| International Medical Case Reports Journal | 0.198 Q4 | 11 | 113 | 204 | 2000 | 123 | 202 | 0.62 | 17.7 |
| Reports in Medical Imaging | 0.190 Q4 | 8 | 1 | 15 | 100 | 14 | 15 | 1.22 | 100 |
| Clinical Medicine Insights: Case Reports | 0.187 Q4 | 12 | 33 | 110 | 678 | 66 | 109 | 0.58 | 20.55 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.144 Q4 | 7 | 193 | 553 | 616 | 20 | 147 | 0.03 | 3.19 |
| Open Access Surgery | 0.125 Q4 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Clinical Medicine Insights: Geriatrics | 0.113 Q4 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 |
| Immunology and Immunogenetics Insights | 0.108 Q4 | 6 | 0 | 3 | 0 | 0 | 3 | 0 | 0 |
| New Zealand Dental Journal | 21 | 1 | 0 | 24 | 0 | 0 | 0 | 24 | |
Daftar Jurnal Index Scopus Medicine 2019
| Title | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) |
| Perspectives in Medicinal Chemistry | 4.450 Q1 | 16 | 0 | 2 | 0 | 28 | 2 | 0 | 0 |
| ImmunoTargets and Therapy | 1.703 Q1 | 7 | 0 | 6 | 0 | 49 | 6 | 1 | 0 |
| Journal of Inflammation Research | 1.538 Q1 | 33 | 34 | 88 | 1702 | 484 | 87 | 4.75 | 50.06 |
| Clinical Epidemiology | 1.500 Q2 | 58 | 93 | 342 | 3593 | 1034 | 329 | 2.86 | 38.63 |
| Breast Cancer: Targets and Therapy | 1.410 Q1 | 27 | 30 | 113 | 1697 | 382 | 108 | 3.21 | 56.57 |
| Journal of Asthma and Allergy | 1.331 Q1 | 30 | 36 | 89 | 1683 | 388 | 87 | 3.62 | 46.75 |
| Psoriasis: Targets and Therapy | 1.324 Q1 | 4 | 0 | 3 | 0 | 17 | 3 | 6 | 0 |
| Lung Cancer: Targets and Therapy | 1.323 Q2 | 16 | 16 | 56 | 860 | 232 | 56 | 4.21 | 53.75 |
| Eye and Brain | 1.307 Q1 | 15 | 6 | 32 | 336 | 137 | 32 | 3.67 | 56 |
| Breast Cancer: Basic and Clinical Research | 1.282 Q2 | 23 | 23 | 57 | 772 | 160 | 56 | 1.79 | 33.57 |
| Biomarker Insights | 1.253 Q1 | 31 | 16 | 72 | 836 | 272 | 72 | 3.77 | 52.25 |
| International Journal of COPD | 1.132 Q1 | 67 | 286 | 1095 | 10413 | 3080 | 1049 | 2.71 | 36.41 |
| Clinical Medicine Insights: Oncology | 1.077 Q2 | 26 | 19 | 57 | 516 | 163 | 56 | 1.97 | 27.16 |
| International Journal of Nanomedicine | 1.061 Q1 | 128 | 687 | 1719 | 36445 | 8957 | 1714 | 5.24 | 53.05 |
| Application of Clinical Genetics | 1.060 Q2 | 32 | 27 | 56 | 1404 | 201 | 55 | 2.85 | 52 |
| Core Evidence (discontinued) | 1.054 Q1 | 23 | 0 | 10 | 0 | 50 | 10 | 5.6 | 0 |
| Clinical Interventions in Aging | 1.000 Q1 | 76 | 225 | 705 | 9348 | 2247 | 672 | 3.12 | 41.55 |
| Nutrition and Metabolic Insights | 0.982 Q2 | 6 | 0 | 8 | 0 | 44 | 8 | 0 | 0 |
| Risk Management and Healthcare Policy | 0.968 Q1 | 22 | 36 | 76 | 1367 | 219 | 73 | 2.67 | 37.97 |
| Infection and Drug Resistance | 0.966 Q2 | 39 | 390 | 350 | 15234 | 1111 | 341 | 3.14 | 39.06 |
| Clinical Ophthalmology | 0.957 Q1 | 56 | 303 | 927 | 9732 | 1947 | 890 | 1.92 | 32.12 |
| OncoTargets and Therapy | 0.954 Q2 | 60 | 1008 | 2243 | 39749 | 6997 | 2235 | 3.26 | 39.43 |
| Clinical and Experimental Gastroenterology | 0.915 Q2 | 30 | 39 | 118 | 2009 | 329 | 117 | 2.43 | 51.51 |
| Journal of Multidisciplinary Healthcare | 0.912 Q1 | 30 | 103 | 189 | 4121 | 519 | 180 | 2.04 | 40.01 |
| International Journal of Women’s Health | 0.907 Q2 | 45 | 62 | 264 | 2364 | 703 | 261 | 2.51 | 38.13 |
| Neuropsychiatric Disease and Treatment | 0.863 Q2 | 67 | 347 | 1046 | 16765 | 2673 | 1009 | 2.23 | 48.31 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 0.862 Q2 | 43 | 249 | 187 | 10895 | 576 | 181 | 2.87 | 43.76 |
| Clinical Pharmacology: Advances and Applications | 0.855 Q2 | 27 | 16 | 56 | 628 | 163 | 56 | 1.92 | 39.25 |
| Substance Abuse: Research and Treatment | 0.838 Q2 | 22 | 30 | 61 | 1301 | 150 | 55 | 2.41 | 43.37 |
| Translational Oncogenomics | 0.838 Q2 | 10 | 0 | 3 | 0 | 11 | 3 | 7 | 0 |
| Integrated Blood Pressure Control | 0.811 Q2 | 20 | 5 | 26 | 380 | 79 | 26 | 2.31 | 76 |
| Journal of Experimental Pharmacology | 0.803 Q2 | 12 | 16 | 26 | 619 | 77 | 26 | 3.56 | 38.69 |
| Cancer Management and Research | 0.797 Q3 | 40 | 930 | 741 | 36009 | 2090 | 737 | 2.82 | 38.72 |
| Vascular Health and Risk Management | 0.796 Q2 | 68 | 51 | 147 | 2545 | 403 | 147 | 2.11 | 49.9 |
| Patient Preference and Adherence | 0.794 Q2 | 48 | 208 | 726 | 7623 | 1619 | 715 | 2.02 | 36.65 |
| Journal of Pain Research | 0.788 Q1 | 49 | 321 | 777 | 13574 | 1905 | 748 | 2.3 | 42.29 |
| International Journal of Nephrology and Renovascular Disease | 0.760 Q2 | 27 | 26 | 106 | 1342 | 273 | 106 | 2.38 | 51.62 |
| Cancer Informatics | 0.748 Q3 | 31 | 33 | 94 | 1203 | 130 | 93 | 1.52 | 36.45 |
| Neurobehavioral HIV Medicine | 0.744 Q2 | 9 | 0 | 5 | 0 | 15 | 5 | 0 | 0 |
| Journal of Blood Medicine | 0.736 Q2 | 18 | 51 | 82 | 1985 | 205 | 81 | 2.02 | 38.92 |
| International Journal of General Medicine | 0.723 Q2 | 36 | 61 | 166 | 2113 | 387 | 160 | 1.95 | 34.64 |
| HIV/AIDS – Research and Palliative Care | 0.704 Q2 | 22 | 41 | 68 | 1524 | 134 | 65 | 1.73 | 37.17 |
| Biologics: Targets and Therapy | 0.697 Q2 | 38 | 17 | 50 | 1157 | 141 | 50 | 2.69 | 68.06 |
| Clinical, Cosmetic and Investigational Dermatology | 0.666 Q2 | 35 | 104 | 187 | 3723 | 449 | 184 | 2.18 | 35.8 |
| Research and Reports in Urology | 0.663 Q2 | 20 | 44 | 90 | 1468 | 165 | 89 | 1.67 | 33.36 |
| Palliative Care | 0.654 Q2 | 7 | 0 | 15 | 0 | 35 | 15 | 2.43 | 0 |
| Psychology Research and Behavior Management | 0.638 Q2 | 30 | 104 | 131 | 5610 | 316 | 131 | 2.35 | 53.94 |
| Virology: Research and Treatment | 0.615 Q3 | 10 | 3 | 10 | 186 | 32 | 9 | 3.22 | 62 |
| Therapeutics and Clinical Risk Management | 0.604 Q2 | 55 | 150 | 668 | 6261 | 1264 | 654 | 1.92 | 41.74 |
| Stem Cells and Cloning: Advances and Applications | 0.602 Q2 | 22 | 5 | 15 | 340 | 42 | 15 | 2.92 | 68 |
| Hepatic Medicine: Evidence and Research | 0.598 Q3 | 2 | 0 | 3 | 0 | 8 | 3 | 0 | 0 |
| Open Access Rheumatology: Research and Reviews | 0.582 Q3 | 14 | 35 | 60 | 1710 | 133 | 58 | 2.02 | 48.86 |
| Integrative Medicine Insights | 0.571 Q1 | 12 | 0 | 10 | 0 | 38 | 10 | 2.25 | 0 |
| Clinical Medicine Insights: Cardiology | 0.555 Q2 | 21 | 21 | 77 | 975 | 142 | 76 | 1.41 | 46.43 |
| ClinicoEconomics and Outcomes Research | 0.544 Q2 | 27 | 69 | 216 | 2577 | 375 | 212 | 1.54 | 37.35 |
| Clinical Medicine Insights: Blood Disorders | 0.534 Q3 | 10 | 5 | 23 | 87 | 53 | 23 | 1.94 | 17.4 |
| Medical Devices: Evidence and Research | 0.488 Q2 | 30 | 45 | 131 | 1594 | 315 | 124 | 2.01 | 35.42 |
| Local and Regional Anesthesia | 0.477 Q2 | 17 | 19 | 46 | 469 | 70 | 42 | 1.79 | 24.68 |
| Drug, Healthcare and Patient Safety | 0.473 Q3 | 24 | 15 | 35 | 565 | 67 | 35 | 1.86 | 37.67 |
| New Zealand Medical Journal | 0.469 Q2 | 50 | 248 | 845 | 2470 | 531 | 523 | 0.63 | 9.96 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.375 Q3 | 21 | 20 | 58 | 595 | 86 | 57 | 1.45 | 29.75 |
| Open Access Emergency Medicine | 0.368 Q2 | 14 | 34 | 60 | 1171 | 68 | 59 | 0.93 | 34.44 |
| Drug Target Insights | 0.324 Q3 | 12 | 5 | 13 | 209 | 30 | 12 | 2.6 | 41.8 |
| Clinical Medicine Insights: Gastroenterology | 0.314 Q3 | 11 | 0 | 38 | 0 | 37 | 38 | 1.04 | 0 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.301 Q3 | 17 | 11 | 28 | 376 | 22 | 28 | 0.5 | 34.18 |
| Fluoride – Quarterly Reports | 0.288 Q3 | 46 | 52 | 131 | 1740 | 135 | 117 | 0.88 | 33.46 |
| Clinical Optometry | 0.285 Q3 | 7 | 21 | 46 | 848 | 44 | 43 | 0.94 | 40.38 |
| Virus Adaptation and Treatment | 0.277 Q3 | 9 | 0 | 8 | 0 | 11 | 8 | 1.17 | 0 |
| Orthopedic Research and Reviews | 0.249 Q3 | 9 | 23 | 27 | 896 | 38 | 27 | 0.62 | 38.96 |
| Open Access Surgery | 0.245 Q3 | 1 | 0 | 3 | 0 | 2 | 3 | 0 | 0 |
| Immunology and Immunogenetics Insights | 0.233 Q4 | 6 | 1 | 4 | 31 | 1 | 3 | 0 | 31 |
| Open Access Journal of Clinical Trials | 0.219 Q3 | 12 | 4 | 18 | 190 | 11 | 18 | 0.77 | 47.5 |
| Clinical Medicine Insights: Therapeutics | 0.206 Q3 | 9 | 0 | 37 | 0 | 31 | 37 | 0.75 | 0 |
| International Medical Case Reports Journal | 0.204 Q3 | 11 | 58 | 224 | 927 | 128 | 220 | 0.53 | 15.98 |
| Clinical Medicine Insights: Case Reports | 0.198 Q3 | 12 | 59 | 80 | 834 | 40 | 79 | 0.45 | 14.14 |
| Clinical Medicine Insights: Geriatrics | 0.188 Q4 | 2 | 0 | 4 | 0 | 2 | 4 | 1 | 0 |
| Reports in Medical Imaging | 0.171 Q4 | 8 | 3 | 15 | 216 | 8 | 15 | 0.67 | 72 |
| Reproductive Biology Insights | 0.149 Q4 | 5 | 0 | 2 | 0 | 1 | 2 | 0 | 0 |
| International Journal of Interferon, Cytokine and Mediator Research | 0.127 Q4 | 11 | 0 | 2 | 0 | 1 | 2 | 0 | 0 |
| Transplant Research and Risk Management | 0.127 Q4 | 6 | 8 | 13 | 451 | 5 | 12 | 0.5 | 56.38 |
| New Zealand Dental Journal | 0.119 Q4 | 21 | 0 | 19 | 0 | 4 | 15 | 0 | 0 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.115 Q4 | 7 | 181 | 552 | 364 | 16 | 163 | 0.03 | 2.01 |
| Nutrition and Dietary Supplements | 0.115 Q4 | 2 | 0 | 3 | 0 | 2 | 3 | 0 | 0 |
| Cell Health and Cytoskeleton | 0.106 Q4 | 11 | 0 | 4 | 0 | 0 | 4 | 0 | 0 |
Daftar Jurnal Index Scopus Medicine 2018
| Title | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) |
| Application of Clinical Genetics | 2.745 Q1 | 32 | 22 | 58 | 718 | 312 | 57 | 4.03 | 32.64 |
| Clinical Epidemiology | 2.523 Q1 | 58 | 163 | 220 | 6077 | 982 | 211 | 3.03 | 37.28 |
| ImmunoTargets and Therapy | 2.355 Q1 | 7 | 0 | 9 | 0 | 73 | 9 | 10.67 | 0 |
| Journal of Inflammation Research | 1.607 Q1 | 33 | 45 | 63 | 3373 | 326 | 63 | 5.02 | 74.96 |
| Translational Oncogenomics | 1.469 Q1 | 10 | 0 | 8 | 0 | 31 | 8 | 1.67 | 0 |
| International Journal of COPD | 1.424 Q1 | 67 | 393 | 971 | 14823 | 3189 | 928 | 3.11 | 37.72 |
| Infection and Drug Resistance | 1.354 Q1 | 39 | 258 | 131 | 10627 | 524 | 128 | 3.09 | 41.19 |
| Stem Cells and Cloning: Advances and Applications | 1.248 Q1 | 22 | 10 | 19 | 561 | 99 | 19 | 2.4 | 56.1 |
| Journal of Asthma and Allergy | 1.245 Q1 | 30 | 33 | 69 | 1818 | 284 | 67 | 4.18 | 55.09 |
| Risk Management and Healthcare Policy | 1.206 Q1 | 22 | 25 | 75 | 1163 | 228 | 72 | 2.39 | 46.52 |
| Breast Cancer: Targets and Therapy | 1.186 Q2 | 27 | 23 | 125 | 1255 | 410 | 120 | 2.91 | 54.57 |
| HIV/AIDS – Research and Palliative Care | 1.135 Q1 | 22 | 27 | 71 | 1090 | 197 | 68 | 1.98 | 40.37 |
| Perspectives in Medicinal Chemistry | 1.113 Q1 | 16 | 0 | 5 | 0 | 36 | 5 | 11 | 0 |
| Clinical, Cosmetic and Investigational Dermatology | 1.111 Q1 | 35 | 74 | 185 | 2867 | 543 | 184 | 2.63 | 38.74 |
| International Journal of Nanomedicine | 1.098 Q1 | 128 | 605 | 1701 | 30552 | 8516 | 1688 | 4.69 | 50.5 |
| Clinical Medicine Insights: Oncology | 1.040 Q2 | 26 | 17 | 60 | 613 | 168 | 58 | 3.1 | 36.06 |
| Clinical and Experimental Gastroenterology | 1.026 Q2 | 30 | 46 | 102 | 2333 | 306 | 102 | 3.08 | 50.72 |
| Clinical Interventions in Aging | 1.001 Q1 | 76 | 260 | 661 | 11281 | 1886 | 610 | 2.63 | 43.39 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 0.997 Q2 | 43 | 90 | 154 | 4065 | 530 | 152 | 3.29 | 45.17 |
| Vascular Health and Risk Management | 0.996 Q1 | 68 | 42 | 167 | 2066 | 581 | 165 | 2.73 | 49.19 |
| Clinical Ophthalmology | 0.994 Q1 | 56 | 324 | 924 | 9783 | 2059 | 875 | 2.06 | 30.19 |
| OncoTargets and Therapy | 0.986 Q2 | 60 | 869 | 1819 | 32783 | 5577 | 1805 | 3.14 | 37.72 |
| Virology: Research and Treatment | 0.979 Q2 | 10 | 2 | 11 | 52 | 30 | 10 | 3.13 | 26 |
| International Journal of Women’s Health | 0.974 Q1 | 45 | 87 | 274 | 3422 | 738 | 271 | 2.29 | 39.33 |
| Breast Cancer: Basic and Clinical Research | 0.951 Q2 | 23 | 19 | 67 | 711 | 189 | 67 | 3.05 | 37.42 |
| Journal of Experimental Pharmacology | 0.937 Q2 | 12 | 9 | 21 | 630 | 68 | 21 | 3.12 | 70 |
| Substance Abuse: Research and Treatment | 0.899 Q2 | 22 | 18 | 76 | 629 | 160 | 73 | 1.63 | 34.94 |
| Clinical Pharmacology: Advances and Applications | 0.897 Q2 | 27 | 18 | 53 | 782 | 136 | 52 | 3 | 43.44 |
| Neuropsychiatric Disease and Treatment | 0.897 Q2 | 67 | 350 | 1034 | 15957 | 2738 | 999 | 2.35 | 45.59 |
| Cancer Management and Research | 0.892 Q2 | 40 | 637 | 135 | 26856 | 342 | 133 | 2.26 | 42.16 |
| Journal of Blood Medicine | 0.871 Q2 | 18 | 29 | 82 | 1138 | 259 | 81 | 3 | 39.24 |
| Journal of Pain Research | 0.842 Q1 | 49 | 333 | 532 | 14008 | 1296 | 508 | 2.18 | 42.07 |
| Journal of Multidisciplinary Healthcare | 0.824 Q2 | 30 | 71 | 176 | 2735 | 423 | 167 | 2.56 | 38.52 |
| International Journal of Nephrology and Renovascular Disease | 0.822 Q2 | 27 | 36 | 91 | 1572 | 229 | 91 | 2.74 | 43.67 |
| Eye and Brain | 0.819 Q2 | 15 | 9 | 29 | 643 | 86 | 29 | 3.22 | 71.44 |
| Research and Reports in Urology | 0.817 Q2 | 20 | 34 | 79 | 1138 | 193 | 79 | 2.07 | 33.47 |
| Clinical Medicine Insights: Cardiology | 0.794 Q2 | 21 | 17 | 112 | 723 | 243 | 110 | 1.78 | 42.53 |
| Open Access Rheumatology: Research and Reviews | 0.776 Q2 | 14 | 20 | 48 | 737 | 106 | 45 | 2.35 | 36.85 |
| Lung Cancer: Targets and Therapy | 0.768 Q3 | 16 | 14 | 51 | 598 | 137 | 51 | 3.05 | 42.71 |
| Cell Health and Cytoskeleton | 0.765 Q2 | 11 | 0 | 17 | 0 | 26 | 17 | 0.5 | 0 |
| Biomarker Insights | 0.758 Q2 | 31 | 24 | 116 | 1491 | 243 | 115 | 2.04 | 62.13 |
| Patient Preference and Adherence | 0.757 Q2 | 48 | 264 | 644 | 10391 | 1421 | 631 | 2.16 | 39.36 |
| Integrative Medicine Insights | 0.734 Q1 | 12 | 1 | 10 | 86 | 36 | 10 | 2.44 | 86 |
| Therapeutics and Clinical Risk Management | 0.725 Q2 | 55 | 268 | 605 | 9943 | 1275 | 586 | 1.87 | 37.1 |
| Integrated Blood Pressure Control | 0.722 Q2 | 20 | 10 | 23 | 451 | 66 | 23 | 2.5 | 45.1 |
| Cancer Informatics | 0.711 Q3 | 31 | 21 | 145 | 697 | 206 | 142 | 1.29 | 33.19 |
| Adolescent Health, Medicine and Therapeutics | 0.700 Q2 | 3 | 0 | 4 | 0 | 18 | 4 | 0 | 0 |
| Biologics: Targets and Therapy | 0.683 Q2 | 38 | 19 | 47 | 947 | 105 | 45 | 2.13 | 49.84 |
| International Journal of General Medicine | 0.683 Q2 | 36 | 58 | 158 | 2190 | 348 | 150 | 2.51 | 37.76 |
| Nutrition and Metabolic Insights | 0.650 Q3 | 6 | 0 | 12 | 0 | 50 | 11 | 4.5 | 0 |
| Medical Devices: Evidence and Research | 0.614 Q2 | 30 | 50 | 130 | 1429 | 384 | 126 | 2.65 | 28.58 |
| ClinicoEconomics and Outcomes Research | 0.609 Q2 | 27 | 75 | 204 | 2752 | 339 | 199 | 1.51 | 36.69 |
| Psychology Research and Behavior Management | 0.596 Q2 | 30 | 60 | 100 | 3176 | 238 | 99 | 2.24 | 52.93 |
| Core Evidence (discontinued) | 0.501 Q2 | 23 | 3 | 15 | 136 | 32 | 15 | 2.29 | 45.33 |
| New Zealand Medical Journal | 0.452 Q2 | 50 | 269 | 886 | 5158 | 602 | 531 | 0.63 | 19.17 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.428 Q3 | 17 | 9 | 43 | 274 | 85 | 43 | 1.58 | 30.44 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.427 Q3 | 21 | 17 | 49 | 719 | 92 | 49 | 1.46 | 42.29 |
| Open Access Emergency Medicine | 0.385 Q2 | 14 | 26 | 45 | 843 | 60 | 44 | 1.18 | 32.42 |
| Local and Regional Anesthesia | 0.371 Q3 | 17 | 18 | 48 | 882 | 62 | 43 | 1.14 | 49 |
| Drug, Healthcare and Patient Safety | 0.343 Q3 | 24 | 11 | 41 | 602 | 63 | 41 | 1.67 | 54.73 |
| Transplant Research and Risk Management | 0.325 Q3 | 6 | 1 | 17 | 107 | 18 | 16 | 0.5 | 107 |
| Fluoride – Quarterly Reports | 0.323 Q3 | 46 | 32 | 132 | 1198 | 141 | 119 | 0.98 | 37.44 |
| International Journal of Interferon, Cytokine and Mediator Research | 0.320 Q4 | 11 | 0 | 6 | 0 | 13 | 6 | 2 | 0 |
| Drug Target Insights | 0.310 Q3 | 12 | 2 | 16 | 48 | 30 | 15 | 1.91 | 24 |
| Clinical Medicine Insights: Blood Disorders | 0.306 Q3 | 10 | 3 | 24 | 106 | 33 | 24 | 1.2 | 35.33 |
| Clinical Medicine Insights: Gastroenterology | 0.297 Q3 | 11 | 17 | 30 | 522 | 25 | 30 | 0.48 | 30.71 |
| Palliative Care | 0.276 Q3 | 7 | 2 | 14 | 32 | 14 | 14 | 1.08 | 16 |
| Clinical Medicine Insights: Case Reports | 0.267 Q3 | 12 | 21 | 84 | 368 | 47 | 83 | 0.44 | 17.52 |
| Clinical Optometry | 0.244 Q3 | 7 | 19 | 37 | 700 | 28 | 37 | 0.52 | 36.84 |
| Psoriasis: Targets and Therapy | 0.240 Q3 | 4 | 0 | 4 | 0 | 7 | 4 | 2.33 | 0 |
| Reports in Medical Imaging | 0.220 Q3 | 8 | 6 | 16 | 168 | 11 | 16 | 0.78 | 28 |
| International Medical Case Reports Journal | 0.209 Q3 | 11 | 68 | 224 | 1222 | 134 | 219 | 0.51 | 17.97 |
| Virus Adaptation and Treatment | 0.198 Q4 | 9 | 2 | 10 | 121 | 9 | 10 | 0.67 | 60.5 |
| Orthopedic Research and Reviews | 0.197 Q4 | 9 | 10 | 33 | 697 | 34 | 33 | 1.47 | 69.7 |
| New Zealand Dental Journal | 0.153 Q4 | 21 | 0 | 41 | 0 | 12 | 35 | 0.16 | 0 |
| Nutrition and Dietary Supplements | 0.146 Q4 | 2 | 0 | 4 | 0 | 3 | 4 | 0.67 | 0 |
| Open Access Journal of Clinical Trials | 0.143 Q4 | 12 | 5 | 19 | 221 | 12 | 19 | 0.38 | 44.2 |
| Reproductive Biology Insights | 0.140 Q4 | 5 | 0 | 4 | 0 | 2 | 4 | 0.5 | 0 |
| Clinical Medicine Insights: Therapeutics | 0.136 Q4 | 9 | 4 | 41 | 238 | 13 | 41 | 0.39 | 59.5 |
| Immunology and Immunogenetics Insights | 0.129 Q4 | 6 | 1 | 6 | 10 | 3 | 5 | 0.67 | 10 |
| Blood and Lymphatic Cancer: Targets and Therapy | 0.124 Q4 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Health Care and Informatics Review Online | 0.124 Q4 | 7 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Hepatic Medicine: Evidence and Research | 0.124 Q4 | 2 | 0 | 3 | 0 | 6 | 3 | 2 | 0 |
| New Zealand Public Health Surveillance Report | 0.124 Q4 | 1 | 1 | 13 | 0 | 0 | 1 | 0 | 0 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.121 Q4 | 7 | 190 | 768 | 350 | 22 | 285 | 0.03 | 1.84 |
| Neurobehavioral HIV Medicine | 0.109 Q4 | 9 | 0 | 6 | 0 | 1 | 6 | 0.2 | 0 |
| Open Access Surgery | 0.108 Q4 | 1 | 0 | 4 | 0 | 2 | 4 | 0.67 | 0 |
| Clinical Medicine Insights: Geriatrics | 0.103 Q4 | 2 | 0 | 7 | 0 | 1 | 7 | 0.25 | 0 |
Daftar Jurnal Index Scopus Medicine 2017
| Title | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) |
| Clinical Epidemiology | 2.819 Q1 | 58 | 73 | 193 | 2589 | 1176 | 188 | 3.63 | 35.47 |
| Perspectives in Medicinal Chemistry | 2.374 Q1 | 16 | 0 | 10 | 0 | 120 | 10 | 5.2 | 0 |
| Application of Clinical Genetics | 2.142 Q1 | 32 | 12 | 67 | 682 | 358 | 66 | 4.63 | 56.83 |
| Translational Oncogenomics | 1.648 Q1 | 10 | 1 | 8 | 28 | 36 | 8 | 5.14 | 28 |
| Journal of Inflammation Research | 1.605 Q1 | 33 | 19 | 61 | 973 | 260 | 61 | 4.16 | 51.21 |
| Infection and Drug Resistance | 1.603 Q1 | 39 | 59 | 107 | 2241 | 512 | 105 | 4.1 | 37.98 |
| Journal of Asthma and Allergy | 1.591 Q1 | 30 | 32 | 51 | 1334 | 258 | 50 | 4.95 | 41.69 |
| Stem Cells and Cloning: Advances and Applications | 1.588 Q1 | 22 | 3 | 27 | 198 | 175 | 27 | 6.13 | 66 |
| Cancer Management and Research | 1.519 Q1 | 40 | 88 | 90 | 4087 | 424 | 85 | 3.81 | 46.44 |
| International Journal of COPD | 1.395 Q1 | 67 | 363 | 741 | 13365 | 2451 | 712 | 2.94 | 36.82 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 1.342 Q1 | 43 | 52 | 163 | 2713 | 620 | 161 | 3.17 | 52.17 |
| Clinical and Experimental Gastroenterology | 1.261 Q1 | 30 | 34 | 113 | 1829 | 405 | 113 | 2.82 | 53.79 |
| International Journal of Nanomedicine | 1.225 Q1 | 128 | 627 | 1567 | 31367 | 7939 | 1545 | 4.6 | 50.03 |
| Clinical, Cosmetic and Investigational Dermatology | 1.157 Q1 | 35 | 61 | 159 | 2249 | 497 | 159 | 2.64 | 36.87 |
| Clinical Medicine Insights: Oncology | 1.129 Q2 | 26 | 15 | 67 | 525 | 215 | 65 | 2.91 | 35 |
| Vascular Health and Risk Management | 1.096 Q1 | 68 | 53 | 192 | 2325 | 650 | 186 | 3.89 | 43.87 |
| Biologics: Targets and Therapy | 1.084 Q2 | 38 | 13 | 56 | 555 | 183 | 54 | 2.76 | 42.69 |
| Breast Cancer: Targets and Therapy | 1.068 Q2 | 27 | 62 | 84 | 2857 | 264 | 80 | 3.08 | 46.08 |
| Clinical Interventions in Aging | 1.056 Q1 | 76 | 231 | 674 | 9761 | 1957 | 623 | 2.54 | 42.26 |
| Clinical Ophthalmology | 1.035 Q2 | 56 | 292 | 978 | 7982 | 2072 | 936 | 2.11 | 27.34 |
| HIV/AIDS – Research and Palliative Care | 1.032 Q1 | 22 | 24 | 67 | 1015 | 173 | 67 | 2.87 | 42.29 |
| International Journal of Women’s Health | 1.025 Q1 | 45 | 102 | 284 | 4244 | 774 | 283 | 2.55 | 41.61 |
| Journal of Experimental Pharmacology | 0.981 Q2 | 12 | 9 | 13 | 501 | 27 | 13 | 1.92 | 55.67 |
| Journal of Pain Research | 0.979 Q1 | 49 | 305 | 296 | 12397 | 850 | 279 | 2.7 | 40.65 |
| Clinical Pharmacology: Advances and Applications | 0.972 Q2 | 27 | 19 | 53 | 708 | 167 | 52 | 2.79 | 37.26 |
| OncoTargets and Therapy | 0.967 Q2 | 60 | 602 | 1464 | 24206 | 4190 | 1455 | 2.81 | 40.21 |
| Journal of Blood Medicine | 0.927 Q2 | 18 | 24 | 64 | 922 | 192 | 63 | 2.76 | 38.42 |
| Neuropsychiatric Disease and Treatment | 0.911 Q2 | 67 | 335 | 973 | 14541 | 2442 | 941 | 2.33 | 43.41 |
| Research and Reports in Urology | 0.905 Q1 | 20 | 30 | 69 | 1070 | 145 | 69 | 2.51 | 35.67 |
| International Journal of Nephrology and Renovascular Disease | 0.903 Q2 | 27 | 33 | 105 | 1567 | 277 | 104 | 1.93 | 47.48 |
| Integrated Blood Pressure Control | 0.865 Q2 | 20 | 6 | 25 | 286 | 89 | 25 | 3.41 | 47.67 |
| Breast Cancer: Basic and Clinical Research | 0.823 Q2 | 23 | 14 | 71 | 849 | 153 | 71 | 2.15 | 60.64 |
| Risk Management and Healthcare Policy | 0.823 Q1 | 22 | 20 | 82 | 798 | 167 | 77 | 1.64 | 39.9 |
| Core Evidence (discontinued) | 0.813 Q1 | 23 | 2 | 26 | 110 | 81 | 25 | 2.62 | 55 |
| Biomarker Insights | 0.810 Q2 | 31 | 19 | 110 | 824 | 231 | 108 | 2.07 | 43.37 |
| Psychology Research and Behavior Management | 0.778 Q2 | 30 | 37 | 93 | 2190 | 244 | 90 | 2.21 | 59.19 |
| Clinical Medicine Insights: Gastroenterology | 0.775 Q2 | 11 | 10 | 28 | 384 | 58 | 28 | 1.15 | 38.4 |
| International Journal of General Medicine | 0.752 Q2 | 36 | 55 | 168 | 1748 | 315 | 160 | 1.78 | 31.78 |
| Therapeutics and Clinical Risk Management | 0.748 Q2 | 55 | 189 | 532 | 6822 | 1238 | 515 | 2.13 | 36.1 |
| Substance Abuse: Research and Treatment | 0.728 Q2 | 22 | 23 | 65 | 1103 | 138 | 61 | 2.42 | 47.96 |
| Patient Preference and Adherence | 0.727 Q2 | 48 | 209 | 611 | 7561 | 1268 | 597 | 1.83 | 36.18 |
| Adolescent Health, Medicine and Therapeutics | 0.713 Q2 | 3 | 0 | 5 | 0 | 19 | 5 | 3.75 | 0 |
| Clinical Medicine Insights: Cardiology | 0.686 Q2 | 21 | 22 | 128 | 1039 | 284 | 127 | 1.99 | 47.23 |
| ClinicoEconomics and Outcomes Research | 0.654 Q2 | 27 | 74 | 184 | 2564 | 325 | 179 | 1.55 | 34.65 |
| Cancer Informatics | 0.640 Q3 | 31 | 35 | 183 | 1306 | 256 | 177 | 1.23 | 37.31 |
| Virology: Research and Treatment | 0.639 Q3 | 10 | 7 | 7 | 479 | 17 | 7 | 2.75 | 68.43 |
| Journal of Multidisciplinary Healthcare | 0.627 Q2 | 30 | 47 | 190 | 2153 | 353 | 182 | 1.89 | 45.81 |
| Local and Regional Anesthesia | 0.601 Q2 | 17 | 16 | 43 | 493 | 82 | 40 | 1.75 | 30.81 |
| Medical Devices: Evidence and Research | 0.586 Q2 | 30 | 27 | 160 | 1079 | 405 | 158 | 2.27 | 39.96 |
| Integrative Medicine Insights | 0.549 Q1 | 12 | 3 | 11 | 272 | 35 | 11 | 3.57 | 90.67 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.537 Q3 | 21 | 16 | 41 | 569 | 84 | 41 | 1.85 | 35.56 |
| Drug Target Insights | 0.529 Q2 | 12 | 3 | 20 | 117 | 45 | 19 | 2.15 | 39 |
| Drug, Healthcare and Patient Safety | 0.481 Q2 | 24 | 11 | 54 | 470 | 99 | 54 | 1.03 | 42.73 |
| Eye and Brain | 0.461 Q3 | 15 | 3 | 38 | 145 | 41 | 37 | 1.27 | 48.33 |
| Open Access Rheumatology: Research and Reviews | 0.445 Q3 | 14 | 24 | 35 | 1020 | 34 | 32 | 1.13 | 42.5 |
| Fluoride – Quarterly Reports | 0.429 Q3 | 46 | 44 | 130 | 1362 | 168 | 118 | 1.11 | 30.95 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.425 Q3 | 17 | 5 | 43 | 160 | 69 | 43 | 1.66 | 32 |
| International Journal of Interferon, Cytokine and Mediator Research | 0.425 Q3 | 11 | 0 | 9 | 0 | 12 | 9 | 0.83 | 0 |
| New Zealand Medical Journal | 0.421 Q3 | 50 | 270 | 925 | 4708 | 584 | 562 | 0.6 | 17.44 |
| Psoriasis: Targets and Therapy | 0.404 Q3 | 4 | 1 | 6 | 89 | 4 | 6 | 0.67 | 89 |
| Cell Health and Cytoskeleton | 0.380 Q3 | 11 | 0 | 20 | 0 | 22 | 20 | 1.24 | 0 |
| Nutrition and Metabolic Insights | 0.331 Q3 | 6 | 0 | 12 | 0 | 30 | 11 | 2.5 | 0 |
| Clinical Medicine Insights: Blood Disorders | 0.314 Q4 | 10 | 14 | 12 | 528 | 23 | 12 | 1.6 | 37.71 |
| Immunology and Immunogenetics Insights | 0.310 Q4 | 6 | 1 | 7 | 153 | 7 | 6 | 1 | 153 |
| Clinical Medicine Insights: Case Reports | 0.283 Q3 | 12 | 30 | 84 | 525 | 53 | 84 | 0.74 | 17.5 |
| Lung Cancer: Targets and Therapy | 0.275 Q3 | 16 | 25 | 36 | 1397 | 38 | 35 | 1.15 | 55.88 |
| Open Access Emergency Medicine | 0.270 Q3 | 14 | 19 | 29 | 417 | 28 | 29 | 0.92 | 21.95 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.252 Q3 | 20 | 0 | 19 | 0 | 9 | 18 | 0 | 0 |
| Clinical Optometry | 0.248 Q3 | 7 | 17 | 29 | 706 | 10 | 29 | 0.5 | 41.53 |
| Orthopedic Research and Reviews | 0.236 Q3 | 9 | 11 | 33 | 619 | 32 | 33 | 1 | 56.27 |
| Neurobehavioral HIV Medicine | 0.207 Q3 | 9 | 0 | 6 | 0 | 6 | 6 | 1 | 0 |
| Virus Adaptation and Treatment | 0.197 Q4 | 9 | 4 | 10 | 410 | 10 | 10 | 1 | 102.5 |
| Open Access Journal of Clinical Trials | 0.192 Q3 | 12 | 8 | 18 | 278 | 13 | 18 | 0.82 | 34.75 |
| International Medical Case Reports Journal | 0.189 Q3 | 11 | 78 | 181 | 1260 | 120 | 178 | 0.64 | 16.15 |
| New Zealand Dental Journal | 0.176 Q3 | 21 | 0 | 66 | 0 | 22 | 50 | 0.17 | 0 |
| Clinical Medicine Insights: Therapeutics | 0.172 Q3 | 9 | 24 | 21 | 1253 | 8 | 21 | 0.41 | 52.21 |
| Reproductive Biology Insights | 0.157 Q4 | 5 | 0 | 7 | 0 | 3 | 7 | 0 | 0 |
| Transplant Research and Risk Management | 0.150 Q3 | 6 | 7 | 24 | 293 | 6 | 24 | 0.3 | 41.86 |
| Reports in Medical Imaging | 0.139 Q4 | 8 | 6 | 20 | 229 | 13 | 20 | 0.7 | 38.17 |
| New Zealand Public Health Surveillance Report | 0.123 Q4 | 1 | 4 | 12 | 1 | 0 | 1 | 0 | 0.25 |
| Nursing praxis in New Zealand inc | 0.117 Q4 | 14 | 0 | 9 | 0 | 3 | 7 | 0 | 0 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.113 Q4 | 7 | 182 | 995 | 462 | 20 | 411 | 0.02 | 2.54 |
| Palliative Care | 0.113 Q4 | 7 | 12 | 4 | 490 | 5 | 4 | 1 | 40.83 |
| Health Care and Informatics Review Online | 0.106 Q4 | 7 | 0 | 5 | 0 | 0 | 4 | 0 | 0 |
| Open Access Surgery | 0.106 Q4 | 1 | 1 | 4 | 36 | 0 | 4 | 0 | 36 |
| Clinical Medicine Insights: Geriatrics | 0.105 Q4 | 2 | 2 | 5 | 208 | 0 | 5 | 0 | 104 |
| ImmunoTargets and Therapy | 7 | 1 | 8 | 60 | 53 | 8 | 6.63 | 60 | |
Daftar Jurnal Index Scopus Medicine 2016
| Title | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) |
| Clinical Epidemiology | 3.767 Q1 | 58 | 106 | 150 | 2352 | 1211 | 145 | 7.98 | 22.19 |
| Perspectives in Medicinal Chemistry | 2.425 Q1 | 16 | 2 | 8 | 277 | 83 | 8 | 10.38 | 138.5 |
| Application of Clinical Genetics | 1.947 Q2 | 32 | 22 | 58 | 1149 | 318 | 58 | 6.2 | 52.23 |
| Stem Cells and Cloning: Advances and Applications | 1.798 Q1 | 22 | 2 | 28 | 179 | 180 | 28 | 6.92 | 89.5 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 1.586 Q1 | 43 | 45 | 169 | 2511 | 744 | 166 | 4.38 | 55.8 |
| Infection and Drug Resistance | 1.551 Q1 | 39 | 33 | 101 | 1683 | 446 | 101 | 4.86 | 51 |
| Clinical Medicine Insights: Blood Disorders | 1.531 Q1 | 10 | 6 | 10 | 289 | 19 | 10 | 2.83 | 48.17 |
| Cancer Management and Research | 1.455 Q1 | 40 | 16 | 117 | 615 | 494 | 114 | 4.68 | 38.44 |
| Journal of Inflammation Research | 1.434 Q1 | 33 | 24 | 52 | 1510 | 198 | 52 | 4.24 | 62.92 |
| Breast Cancer: Targets and Therapy | 1.378 Q1 | 27 | 28 | 68 | 1231 | 237 | 68 | 3.77 | 43.96 |
| International Journal of COPD | 1.257 Q1 | 67 | 339 | 490 | 12431 | 1679 | 462 | 3.49 | 36.67 |
| Clinical and Experimental Gastroenterology | 1.226 Q1 | 30 | 38 | 104 | 2421 | 356 | 104 | 3.96 | 63.71 |
| International Journal of Nanomedicine | 1.174 Q1 | 128 | 487 | 1503 | 23629 | 7271 | 1474 | 4.52 | 48.52 |
| Integrated Blood Pressure Control | 1.170 Q1 | 20 | 10 | 29 | 524 | 112 | 29 | 3.73 | 52.4 |
| Biologics: Targets and Therapy | 1.133 Q1 | 38 | 18 | 65 | 1047 | 271 | 63 | 3.74 | 58.17 |
| Translational Oncogenomics | 1.093 Q2 | 10 | 2 | 6 | 219 | 28 | 6 | 4.67 | 109.5 |
| Clinical Interventions in Aging | 1.086 Q1 | 76 | 214 | 659 | 8613 | 2046 | 622 | 2.83 | 40.25 |
| Journal of Pain Research | 1.045 Q1 | 49 | 139 | 233 | 5953 | 734 | 225 | 3.01 | 42.83 |
| Clinical, Cosmetic and Investigational Dermatology | 0.993 Q1 | 35 | 52 | 144 | 2161 | 450 | 144 | 2.99 | 41.56 |
| OncoTargets and Therapy | 0.990 Q2 | 60 | 772 | 891 | 29367 | 2675 | 882 | 2.85 | 38.04 |
| International Journal of Women’s Health | 0.972 Q2 | 45 | 75 | 303 | 3779 | 837 | 299 | 2.89 | 50.39 |
| Core Evidence (discontinued) | 0.965 Q1 | 23 | 5 | 28 | 371 | 112 | 27 | 4.1 | 74.2 |
| Neuropsychiatric Disease and Treatment | 0.945 Q2 | 67 | 361 | 821 | 16124 | 2154 | 804 | 2.56 | 44.66 |
| Clinical Pharmacology: Advances and Applications | 0.941 Q2 | 27 | 19 | 62 | 1003 | 181 | 58 | 3.18 | 52.79 |
| Clinical Ophthalmology | 0.927 Q2 | 56 | 311 | 1015 | 9915 | 1884 | 975 | 1.91 | 31.88 |
| Psychology Research and Behavior Management | 0.926 Q2 | 30 | 34 | 75 | 1733 | 220 | 72 | 2.56 | 50.97 |
| Clinical Medicine Insights: Oncology | 0.922 Q2 | 26 | 25 | 62 | 1529 | 169 | 61 | 2.98 | 61.16 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.912 Q2 | 21 | 25 | 26 | 1007 | 99 | 26 | 3.13 | 40.28 |
| Vascular Health and Risk Management | 0.912 Q1 | 68 | 52 | 214 | 2739 | 641 | 207 | 3.08 | 52.67 |
| International Journal of Nephrology and Renovascular Disease | 0.904 Q1 | 27 | 37 | 104 | 1810 | 249 | 102 | 2.72 | 48.92 |
| ClinicoEconomics and Outcomes Research | 0.885 Q1 | 27 | 67 | 174 | 2590 | 421 | 171 | 2 | 38.66 |
| HIV/AIDS – Research and Palliative Care | 0.880 Q1 | 22 | 17 | 81 | 648 | 194 | 81 | 2.92 | 38.12 |
| Clinical Medicine Insights: Gastroenterology | 0.855 Q2 | 11 | 11 | 22 | 559 | 75 | 22 | 3 | 50.82 |
| Journal of Asthma and Allergy | 0.806 Q2 | 30 | 24 | 41 | 1236 | 119 | 40 | 3.56 | 51.5 |
| Drug Target Insights | 0.790 Q2 | 12 | 8 | 18 | 333 | 58 | 18 | 1.83 | 41.63 |
| Patient Preference and Adherence | 0.790 Q2 | 48 | 253 | 477 | 9849 | 1074 | 466 | 2.01 | 38.93 |
| Therapeutics and Clinical Risk Management | 0.765 Q2 | 55 | 211 | 378 | 8586 | 931 | 365 | 2.52 | 40.69 |
| Journal of Blood Medicine | 0.751 Q2 | 18 | 29 | 35 | 1458 | 107 | 35 | 3.06 | 50.28 |
| Breast Cancer: Basic and Clinical Research | 0.733 Q2 | 23 | 24 | 53 | 1367 | 105 | 53 | 1.83 | 56.96 |
| Biomarker Insights | 0.699 Q2 | 31 | 29 | 96 | 1744 | 193 | 94 | 1.77 | 60.14 |
| Eye and Brain | 0.659 Q2 | 15 | 20 | 18 | 1378 | 24 | 17 | 1.33 | 68.9 |
| Clinical Medicine Insights: Cardiology | 0.640 Q2 | 21 | 38 | 105 | 1541 | 200 | 104 | 1.87 | 40.55 |
| International Journal of General Medicine | 0.639 Q2 | 36 | 53 | 223 | 1987 | 394 | 213 | 1.69 | 37.49 |
| Neurobehavioral HIV Medicine | 0.615 Q2 | 9 | 5 | 3 | 541 | 5 | 3 | 2 | 108.2 |
| Research and Reports in Urology | 0.615 Q2 | 20 | 26 | 74 | 997 | 119 | 74 | 2.05 | 38.35 |
| Substance Abuse: Research and Treatment | 0.600 Q2 | 22 | 20 | 63 | 1025 | 115 | 56 | 1.49 | 51.25 |
| Cancer Informatics | 0.597 Q3 | 31 | 38 | 163 | 1909 | 216 | 156 | 1.33 | 50.24 |
| Risk Management and Healthcare Policy | 0.573 Q2 | 22 | 31 | 60 | 1297 | 112 | 57 | 2 | 41.84 |
| Medical Devices: Evidence and Research | 0.564 Q2 | 30 | 54 | 133 | 1720 | 308 | 133 | 2.37 | 31.85 |
| Journal of Multidisciplinary Healthcare | 0.537 Q2 | 30 | 71 | 163 | 3245 | 259 | 160 | 1.5 | 45.7 |
| Adolescent Health, Medicine and Therapeutics | 0.533 Q2 | 3 | 0 | 5 | 0 | 13 | 5 | 2.6 | 0 |
| Drug, Healthcare and Patient Safety | 0.531 Q2 | 24 | 13 | 66 | 469 | 110 | 60 | 1.93 | 36.08 |
| Immunology and Immunogenetics Insights | 0.478 Q3 | 6 | 2 | 6 | 67 | 16 | 6 | 3.2 | 33.5 |
| Local and Regional Anesthesia | 0.458 Q2 | 17 | 12 | 39 | 407 | 51 | 38 | 1.26 | 33.92 |
| Virology: Research and Treatment | 0.410 Q3 | 10 | 1 | 11 | 22 | 18 | 11 | 2.17 | 22 |
| New Zealand Medical Journal | 0.357 Q3 | 50 | 306 | 1005 | 4559 | 516 | 602 | 0.47 | 14.9 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.356 Q3 | 17 | 14 | 37 | 850 | 51 | 37 | 1.34 | 60.71 |
| Fluoride – Quarterly Reports | 0.332 Q3 | 46 | 55 | 108 | 1702 | 181 | 98 | 1.84 | 30.95 |
| Orthopedic Research and Reviews | 0.320 Q3 | 9 | 6 | 27 | 534 | 13 | 27 | 0.48 | 89 |
| Virus Adaptation and Treatment | 0.316 Q3 | 9 | 2 | 10 | 227 | 10 | 10 | 1.13 | 113.5 |
| Open Access Journal of Clinical Trials | 0.305 Q3 | 12 | 5 | 27 | 140 | 24 | 25 | 0.54 | 28 |
| Reports in Medical Imaging | 0.235 Q3 | 8 | 3 | 26 | 115 | 27 | 25 | 0.76 | 38.33 |
| Psoriasis: Targets and Therapy | 0.233 Q3 | 4 | 2 | 4 | 113 | 2 | 4 | 0.5 | 56.5 |
| Clinical Medicine Insights: Case Reports | 0.223 Q3 | 12 | 29 | 93 | 493 | 65 | 93 | 0.51 | 17 |
| New Zealand Dental Journal | 0.219 Q3 | 21 | 19 | 70 | 326 | 35 | 49 | 0.32 | 17.16 |
| Clinical Medicine Insights: Therapeutics | 0.212 Q3 | 9 | 9 | 25 | 551 | 11 | 25 | 0.25 | 61.22 |
| Nursing praxis in New Zealand inc | 0.211 Q3 | 14 | 0 | 21 | 0 | 9 | 16 | 0.67 | 0 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.211 Q3 | 20 | 0 | 19 | 0 | 7 | 18 | 0.37 | 0 |
| Lung Cancer: Targets and Therapy | 0.192 Q4 | 16 | 17 | 28 | 943 | 9 | 27 | 0.32 | 55.47 |
| Integrative Medicine Insights | 0.186 Q3 | 12 | 6 | 6 | 322 | 6 | 6 | 1.2 | 53.67 |
| International Journal of Interferon, Cytokine and Mediator Research | 0.186 Q4 | 11 | 2 | 10 | 458 | 7 | 10 | 0.43 | 229 |
| Cell Health and Cytoskeleton | 0.182 Q4 | 11 | 4 | 17 | 359 | 8 | 17 | 0.5 | 89.75 |
| Open Access Emergency Medicine | 0.167 Q3 | 14 | 15 | 26 | 595 | 11 | 26 | 0.36 | 39.67 |
| International Medical Case Reports Journal | 0.162 Q4 | 11 | 78 | 125 | 1258 | 70 | 124 | 0.43 | 16.13 |
| Journal of Experimental Pharmacology | 0.162 Q3 | 12 | 8 | 6 | 369 | 8 | 6 | 0.8 | 46.13 |
| Nutrition and Metabolic Insights | 0.133 Q4 | 6 | 8 | 4 | 656 | 7 | 3 | 1.75 | 82 |
| Palliative Care | 0.133 Q4 | 7 | 1 | 9 | 19 | 4 | 9 | 0.67 | 19 |
| New Zealand Public Health Surveillance Report | 0.123 Q4 | 1 | 3 | 9 | 4 | 1 | 1 | 0.11 | 1.33 |
| Transplant Research and Risk Management | 0.123 Q4 | 6 | 5 | 22 | 211 | 4 | 22 | 0.21 | 42.2 |
| Open Access Rheumatology: Research and Reviews | 0.113 Q4 | 14 | 16 | 28 | 659 | 4 | 27 | 0.11 | 41.19 |
| Open Access Surgery | 0.111 Q4 | 1 | 2 | 2 | 192 | 0 | 2 | 0 | 96 |
| Reproductive Biology Insights | 0.109 Q4 | 5 | 2 | 7 | 102 | 3 | 7 | 0.4 | 51 |
| Clinical Medicine Insights: Geriatrics | 0.105 Q4 | 2 | 2 | 5 | 162 | 0 | 5 | 0 | 81 |
| Health Care and Informatics Review Online | 0.103 Q4 | 7 | 0 | 8 | 0 | 2 | 7 | 0.2 | 0 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.103 Q4 | 7 | 180 | 1117 | 0 | 25 | 436 | 0.02 | 0 |
| Clinical Optometry | 0.101 Q4 | 7 | 10 | 19 | 538 | 2 | 19 | 0.11 | 53.8 |
| Hepatic Medicine: Evidence and Research | 2 | 3 | 0 | 126 | 0 | 0 | 0 | 42 | |
| ImmunoTargets and Therapy | 7 | 5 | 3 | 606 | 0 | 3 | 0 | 121.2 | |
| Nutrition and Dietary Supplements | 2 | 3 | 1 | 231 | 0 | 1 | 0 | 77 | |
Daftar Jurnal Index Scopus Medicine 2015
| Title | SJR | H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) |
| Clinical Epidemiology | 3.098 Q1 | 58 | 41 | 163 | 1924 | 988 | 150 | 6.9 | 46.93 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 1.463 Q1 | 43 | 57 | 154 | 2744 | 689 | 150 | 4.69 | 48.14 |
| Cancer Management and Research | 1.386 Q1 | 40 | 31 | 133 | 2022 | 539 | 128 | 4.69 | 65.23 |
| Application of Clinical Genetics | 1.327 Q2 | 32 | 24 | 47 | 2331 | 181 | 46 | 4.5 | 97.13 |
| International Journal of Nanomedicine | 1.323 Q1 | 128 | 587 | 1435 | 28830 | 7622 | 1408 | 4.65 | 49.11 |
| Clinical Pharmacology: Advances and Applications | 1.290 Q1 | 27 | 15 | 58 | 451 | 196 | 54 | 3.66 | 30.07 |
| Perspectives in Medicinal Chemistry | 1.285 Q1 | 16 | 3 | 5 | 193 | 29 | 5 | 5.8 | 64.33 |
| Infection and Drug Resistance | 1.263 Q1 | 39 | 39 | 82 | 2276 | 321 | 82 | 4.31 | 58.36 |
| International Journal of COPD | 1.245 Q1 | 67 | 269 | 306 | 10508 | 1170 | 283 | 3.53 | 39.06 |
| Biologics: Targets and Therapy | 1.172 Q1 | 38 | 16 | 95 | 839 | 370 | 94 | 4.84 | 52.44 |
| OncoTargets and Therapy | 1.140 Q1 | 60 | 445 | 497 | 15599 | 1700 | 496 | 3.51 | 35.05 |
| Adolescent Health, Medicine and Therapeutics | 1.106 Q1 | 3 | 4 | 1 | 285 | 5 | 1 | 5 | 71.25 |
| Clinical, Cosmetic and Investigational Dermatology | 1.080 Q1 | 35 | 72 | 100 | 3275 | 299 | 99 | 3.38 | 45.49 |
| Core Evidence (discontinued) | 1.051 Q1 | 23 | 8 | 32 | 471 | 130 | 31 | 4.3 | 58.88 |
| Breast Cancer: Targets and Therapy | 1.041 Q2 | 27 | 35 | 54 | 2302 | 154 | 53 | 3.73 | 65.77 |
| Journal of Inflammation Research | 1.035 Q2 | 33 | 20 | 49 | 1408 | 139 | 49 | 3.59 | 70.4 |
| Stem Cells and Cloning: Advances and Applications | 1.034 Q1 | 22 | 14 | 18 | 1339 | 81 | 18 | 5.21 | 95.64 |
| Clinical and Experimental Gastroenterology | 1.008 Q2 | 30 | 30 | 97 | 1527 | 330 | 96 | 3.58 | 50.9 |
| Clinical Interventions in Aging | 0.945 Q1 | 76 | 216 | 511 | 8248 | 1363 | 495 | 2.51 | 38.19 |
| HIV/AIDS – Research and Palliative Care | 0.936 Q1 | 22 | 30 | 72 | 1540 | 126 | 72 | 1.84 | 51.33 |
| Journal of Pain Research | 0.919 Q1 | 49 | 88 | 207 | 3781 | 664 | 202 | 3.07 | 42.97 |
| Vascular Health and Risk Management | 0.900 Q1 | 68 | 62 | 225 | 3538 | 622 | 219 | 2.74 | 57.06 |
| Journal of Asthma and Allergy | 0.896 Q2 | 30 | 13 | 38 | 691 | 123 | 38 | 3.11 | 53.15 |
| International Journal of Women’s Health | 0.851 Q2 | 45 | 97 | 278 | 4487 | 668 | 274 | 2.46 | 46.26 |
| Drug Target Insights | 0.845 Q2 | 12 | 5 | 17 | 225 | 52 | 17 | 3.23 | 45 |
| Clinical Medicine Insights: Oncology | 0.834 Q2 | 26 | 20 | 86 | 859 | 205 | 86 | 3.07 | 42.95 |
| Journal of Blood Medicine | 0.826 Q2 | 18 | 29 | 6 | 1390 | 23 | 6 | 3.83 | 47.93 |
| Biomarker Insights | 0.800 Q2 | 31 | 68 | 44 | 5487 | 109 | 43 | 1.86 | 80.69 |
| Clinical Ophthalmology | 0.799 Q2 | 56 | 321 | 1010 | 9546 | 1674 | 986 | 1.61 | 29.74 |
| Breast Cancer: Basic and Clinical Research | 0.787 Q2 | 23 | 29 | 40 | 1496 | 82 | 40 | 2.29 | 51.59 |
| ClinicoEconomics and Outcomes Research | 0.785 Q2 | 27 | 63 | 155 | 2005 | 323 | 154 | 2.28 | 31.83 |
| Neuropsychiatric Disease and Treatment | 0.777 Q2 | 67 | 338 | 572 | 16127 | 1274 | 557 | 2.27 | 47.71 |
| Patient Preference and Adherence | 0.777 Q2 | 48 | 182 | 389 | 6394 | 875 | 385 | 2.11 | 35.13 |
| Clinical Medicine Insights: Gastroenterology | 0.772 Q2 | 11 | 9 | 22 | 361 | 62 | 22 | 4.15 | 40.11 |
| Substance Abuse: Research and Treatment | 0.740 Q2 | 22 | 33 | 42 | 1646 | 92 | 36 | 2.4 | 49.88 |
| Eye and Brain | 0.735 Q2 | 15 | 6 | 12 | 648 | 13 | 11 | 1.08 | 108 |
| Therapeutics and Clinical Risk Management | 0.706 Q2 | 55 | 205 | 220 | 9412 | 539 | 213 | 2.4 | 45.91 |
| Integrated Blood Pressure Control | 0.694 Q2 | 20 | 7 | 26 | 371 | 84 | 26 | 3.64 | 53 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.659 Q3 | 21 | 8 | 28 | 246 | 61 | 28 | 2.5 | 30.75 |
| International Journal of Nephrology and Renovascular Disease | 0.628 Q2 | 27 | 21 | 105 | 701 | 222 | 103 | 2.33 | 33.38 |
| Cell Health and Cytoskeleton | 0.612 Q2 | 11 | 13 | 14 | 1810 | 29 | 14 | 0.5 | 139.23 |
| Psychology Research and Behavior Management | 0.600 Q2 | 30 | 29 | 69 | 1834 | 146 | 65 | 2.65 | 63.24 |
| International Journal of General Medicine | 0.581 Q2 | 36 | 50 | 309 | 1692 | 500 | 299 | 1.73 | 33.84 |
| Cancer Informatics | 0.563 Q3 | 31 | 72 | 106 | 2875 | 127 | 101 | 1.03 | 39.93 |
| Medical Devices: Evidence and Research | 0.558 Q2 | 30 | 49 | 99 | 1684 | 210 | 99 | 2.19 | 34.37 |
| Drug, Healthcare and Patient Safety | 0.531 Q2 | 24 | 17 | 66 | 635 | 119 | 60 | 1.69 | 37.35 |
| Journal of Multidisciplinary Healthcare | 0.432 Q3 | 30 | 58 | 143 | 2086 | 208 | 142 | 1.38 | 35.97 |
| Risk Management and Healthcare Policy | 0.410 Q2 | 22 | 24 | 52 | 1224 | 87 | 48 | 1.22 | 51 |
| Clinical Medicine Insights: Cardiology | 0.393 Q3 | 21 | 52 | 73 | 2396 | 103 | 73 | 1.47 | 46.08 |
| Local and Regional Anesthesia | 0.389 Q2 | 17 | 20 | 26 | 633 | 44 | 26 | 1.42 | 31.65 |
| Lung Cancer: Targets and Therapy | 0.357 Q3 | 16 | 9 | 28 | 563 | 13 | 27 | 0.47 | 62.56 |
| International Journal of Interferon, Cytokine and Mediator Research | 0.354 Q3 | 11 | 4 | 13 | 452 | 10 | 13 | 0.5 | 113 |
| Open Access Journal of Clinical Trials | 0.351 Q3 | 12 | 6 | 37 | 243 | 30 | 35 | 0.48 | 40.5 |
| Research and Reports in Urology | 0.347 Q2 | 20 | 23 | 62 | 1026 | 80 | 62 | 1.31 | 44.61 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.346 Q3 | 17 | 24 | 13 | 2209 | 17 | 13 | 1.31 | 92.04 |
| Virology: Research and Treatment | 0.345 Q3 | 10 | 3 | 8 | 137 | 6 | 8 | 0.75 | 45.67 |
| Virus Adaptation and Treatment | 0.333 Q3 | 9 | 4 | 15 | 338 | 12 | 15 | 0.33 | 84.5 |
| Journal of Experimental Pharmacology | 0.323 Q3 | 12 | 4 | 4 | 322 | 9 | 4 | 3 | 80.5 |
| Neurobehavioral HIV Medicine | 0.313 Q3 | 9 | 1 | 6 | 49 | 8 | 6 | 1 | 49 |
| New Zealand Medical Journal | 0.300 Q3 | 50 | 310 | 1055 | 4742 | 503 | 698 | 0.45 | 15.3 |
| Fluoride – Quarterly Reports | 0.287 Q3 | 46 | 33 | 120 | 952 | 109 | 110 | 0.87 | 28.85 |
| New Zealand Dental Journal | 0.287 Q3 | 21 | 22 | 76 | 362 | 40 | 47 | 0.65 | 16.45 |
| Translational Oncogenomics | 0.287 Q3 | 10 | 5 | 2 | 791 | 2 | 2 | 1 | 158.2 |
| Nursing praxis in New Zealand inc | 0.268 Q3 | 14 | 0 | 33 | 0 | 14 | 25 | 0.33 | 0 |
| Open Access Rheumatology: Research and Reviews | 0.252 Q3 | 14 | 8 | 33 | 404 | 15 | 33 | 0.45 | 50.5 |
| Clinical Medicine Insights: Blood Disorders | 0.237 Q4 | 10 | 4 | 8 | 113 | 7 | 8 | 0.83 | 28.25 |
| Reports in Medical Imaging | 0.229 Q3 | 8 | 7 | 25 | 390 | 26 | 24 | 1.21 | 55.71 |
| Integrative Medicine Insights | 0.203 Q3 | 12 | 1 | 11 | 137 | 10 | 11 | 0.4 | 137 |
| Clinical Medicine Insights: Case Reports | 0.202 Q3 | 12 | 25 | 98 | 396 | 76 | 98 | 0.76 | 15.84 |
| Clinical Medicine Insights: Therapeutics | 0.186 Q3 | 9 | 8 | 39 | 684 | 19 | 39 | 0.76 | 85.5 |
| International Medical Case Reports Journal | 0.171 Q3 | 11 | 68 | 76 | 1033 | 44 | 76 | 0.67 | 15.19 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.152 Q4 | 20 | 0 | 58 | 0 | 13 | 54 | 0.32 | 0 |
| Immunology and Immunogenetics Insights | 0.144 Q4 | 6 | 3 | 4 | 217 | 1 | 4 | 0 | 72.33 |
| Open Access Emergency Medicine | 0.133 Q4 | 14 | 11 | 25 | 453 | 8 | 25 | 0.4 | 41.18 |
| Health Care and Informatics Review Online | 0.128 Q4 | 7 | 1 | 16 | 14 | 3 | 13 | 0.14 | 14 |
| Clinical Optometry | 0.125 Q4 | 7 | 10 | 9 | 779 | 1 | 9 | 0.11 | 77.9 |
| Open Access Surgery | 0.123 Q4 | 1 | 1 | 1 | 99 | 0 | 1 | 0 | 99 |
| Reproductive Biology Insights | 0.121 Q4 | 5 | 2 | 5 | 101 | 1 | 5 | 0.2 | 50.5 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.114 Q4 | 7 | 406 | 984 | 503 | 24 | 369 | 0.02 | 1.24 |
| Palliative Care | 0.113 Q4 | 7 | 1 | 9 | 18 | 1 | 9 | 0.13 | 18 |
| Clinical Medicine Insights: Geriatrics | 0.111 Q4 | 2 | 3 | 2 | 122 | 1 | 2 | 0.5 | 40.67 |
| New Zealand Public Health Surveillance Report | 0.111 Q4 | 1 | 6 | 21 | 41 | 0 | 2 | 0 | 6.83 |
| Psoriasis: Targets and Therapy | 0.108 Q4 | 4 | 1 | 3 | 71 | 0 | 3 | 0 | 71 |
| Transplant Research and Risk Management | 0.108 Q4 | 6 | 5 | 22 | 428 | 8 | 22 | 0.35 | 85.6 |
| Orthopedic Research and Reviews | 0.106 Q4 | 9 | 16 | 11 | 1153 | 6 | 11 | 0.55 | 72.06 |
| Blood and Lymphatic Cancer: Targets and Therapy | 1 | 1 | 0 | 158 | 0 | 0 | 0 | 158 | |
| ImmunoTargets and Therapy | 7 | 3 | 0 | 226 | 0 | 0 | 0 | 75.33 | |
| Nutrition and Dietary Supplements | 2 | 1 | 0 | 76 | 0 | 0 | 0 | 76 | |
| Nutrition and Metabolic Insights | 6 | 4 | 0 | 247 | 0 | 0 | 0 | 61.75 | |
Daftar Jurnal Index Scopus Medicine 2014
| Title | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) |
| Clinical Epidemiology | 1.644 Q2 | 58 | 46 | 161 | 2449 | 597 | 145 | 3.84 | 53.24 |
| International Journal of Nanomedicine | 1.306 Q1 | 128 | 493 | 1274 | 20779 | 6710 | 1259 | 4.94 | 42.15 |
| International Journal of COPD | 1.293 Q1 | 67 | 133 | 247 | 6417 | 901 | 230 | 3.46 | 48.25 |
| Cancer Management and Research | 1.224 Q2 | 40 | 43 | 121 | 3022 | 423 | 119 | 3.88 | 70.28 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 1.149 Q1 | 43 | 61 | 108 | 3670 | 404 | 105 | 3.74 | 60.16 |
| Biologics: Targets and Therapy | 1.096 Q1 | 38 | 22 | 80 | 1520 | 327 | 78 | 4.19 | 69.09 |
| OncoTargets and Therapy | 1.089 Q1 | 60 | 247 | 269 | 10812 | 855 | 268 | 3.26 | 43.77 |
| Journal of Experimental Pharmacology | 0.994 Q2 | 12 | 1 | 3 | 23 | 9 | 3 | 3 | 23 |
| Journal of Pain Research | 0.994 Q1 | 49 | 69 | 182 | 3654 | 544 | 180 | 3.15 | 52.96 |
| Core Evidence (discontinued) | 0.983 Q1 | 23 | 13 | 26 | 713 | 105 | 26 | 4.21 | 54.85 |
| Cancer Informatics | 0.947 Q2 | 31 | 73 | 55 | 2995 | 106 | 53 | 1.88 | 41.03 |
| Biomarker Insights | 0.937 Q1 | 31 | 13 | 48 | 424 | 131 | 48 | 2.74 | 32.62 |
| Cell Health and Cytoskeleton | 0.935 Q1 | 11 | 3 | 15 | 256 | 43 | 14 | 2.73 | 85.33 |
| Vascular Health and Risk Management | 0.883 Q1 | 68 | 78 | 239 | 2644 | 660 | 236 | 2.69 | 33.9 |
| Journal of Asthma and Allergy | 0.867 Q2 | 30 | 14 | 35 | 807 | 104 | 34 | 3.13 | 57.64 |
| Clinical Pharmacology: Advances and Applications | 0.844 Q2 | 27 | 19 | 46 | 987 | 128 | 41 | 2.72 | 51.95 |
| Clinical Interventions in Aging | 0.824 Q2 | 76 | 244 | 306 | 10201 | 844 | 298 | 2.71 | 41.81 |
| Journal of Inflammation Research | 0.816 Q2 | 33 | 17 | 45 | 823 | 101 | 45 | 1.56 | 48.41 |
| Substance Abuse: Research and Treatment | 0.784 Q2 | 22 | 12 | 35 | 430 | 80 | 31 | 2.47 | 35.83 |
| Infection and Drug Resistance | 0.777 Q2 | 39 | 35 | 71 | 2165 | 170 | 70 | 2.26 | 61.86 |
| Clinical Ophthalmology | 0.764 Q2 | 56 | 346 | 957 | 9831 | 1672 | 938 | 1.57 | 28.41 |
| ClinicoEconomics and Outcomes Research | 0.759 Q2 | 27 | 54 | 119 | 1819 | 262 | 119 | 2.05 | 33.69 |
| Drug, Healthcare and Patient Safety | 0.733 Q2 | 24 | 24 | 58 | 1267 | 93 | 52 | 1.6 | 52.79 |
| Application of Clinical Genetics | 0.732 Q3 | 32 | 21 | 39 | 1920 | 78 | 38 | 2.27 | 91.43 |
| Clinical, Cosmetic and Investigational Dermatology | 0.725 Q2 | 35 | 35 | 69 | 1797 | 125 | 68 | 1.83 | 51.34 |
| Patient Preference and Adherence | 0.695 Q2 | 48 | 176 | 284 | 6644 | 655 | 281 | 2.27 | 37.75 |
| Neuropsychiatric Disease and Treatment | 0.676 Q2 | 67 | 274 | 380 | 12545 | 887 | 374 | 2.15 | 45.78 |
| Clinical Medicine Insights: Oncology | 0.669 Q3 | 26 | 22 | 96 | 889 | 210 | 96 | 2.27 | 40.41 |
| HIV/AIDS – Research and Palliative Care | 0.659 Q2 | 22 | 20 | 67 | 807 | 119 | 67 | 1.83 | 40.35 |
| Breast Cancer: Basic and Clinical Research | 0.641 Q3 | 23 | 18 | 45 | 811 | 101 | 45 | 2.14 | 45.06 |
| International Journal of Women’s Health | 0.624 Q2 | 45 | 112 | 219 | 5734 | 468 | 213 | 2.03 | 51.2 |
| Therapeutics and Clinical Risk Management | 0.619 Q2 | 55 | 116 | 111 | 5592 | 219 | 105 | 2.01 | 48.21 |
| Clinical and Experimental Gastroenterology | 0.561 Q2 | 30 | 45 | 83 | 3212 | 172 | 82 | 2.08 | 71.38 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.517 Q2 | 17 | 5 | 21 | 150 | 44 | 21 | 0.88 | 30 |
| Risk Management and Healthcare Policy | 0.507 Q2 | 22 | 27 | 37 | 840 | 68 | 34 | 1.72 | 31.11 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.490 Q3 | 21 | 8 | 31 | 363 | 57 | 31 | 1.75 | 45.38 |
| Integrated Blood Pressure Control | 0.490 Q2 | 20 | 8 | 20 | 621 | 50 | 20 | 2.61 | 77.63 |
| International Journal of Nephrology and Renovascular Disease | 0.481 Q3 | 27 | 47 | 76 | 2300 | 102 | 74 | 1.47 | 48.94 |
| Clinical Medicine Insights: Cardiology | 0.478 Q3 | 21 | 38 | 51 | 1550 | 70 | 51 | 1.54 | 40.79 |
| International Journal of General Medicine | 0.475 Q2 | 36 | 65 | 279 | 2479 | 428 | 273 | 1.5 | 38.14 |
| Neurobehavioral HIV Medicine | 0.456 Q2 | 9 | 0 | 15 | 0 | 16 | 15 | 1 | 0 |
| Drug Target Insights | 0.435 Q2 | 12 | 7 | 12 | 311 | 23 | 12 | 2.2 | 44.43 |
| Psychology Research and Behavior Management | 0.429 Q2 | 30 | 30 | 53 | 2079 | 98 | 51 | 1.72 | 69.3 |
| Journal of Multidisciplinary Healthcare | 0.406 Q3 | 30 | 61 | 127 | 2520 | 191 | 126 | 1.33 | 41.31 |
| Stem Cells and Cloning: Advances and Applications | 0.393 Q3 | 22 | 11 | 14 | 977 | 17 | 13 | 0.86 | 88.82 |
| Translational Oncogenomics | 0.357 Q3 | 10 | 1 | 1 | 104 | 1 | 1 | 1 | 104 |
| Breast Cancer: Targets and Therapy | 0.344 Q3 | 27 | 21 | 50 | 1225 | 61 | 48 | 1.27 | 58.33 |
| New Zealand Medical Journal | 0.343 Q3 | 50 | 309 | 1154 | 4854 | 555 | 795 | 0.44 | 15.71 |
| International Journal of Interferon, Cytokine and Mediator Research | 0.339 Q3 | 11 | 3 | 20 | 334 | 30 | 20 | 0.7 | 111.33 |
| Local and Regional Anesthesia | 0.312 Q3 | 17 | 11 | 26 | 231 | 37 | 26 | 1.4 | 21 |
| Fluoride – Quarterly Reports | 0.298 Q3 | 46 | 42 | 112 | 1200 | 70 | 102 | 0.67 | 28.57 |
| Medical Devices: Evidence and Research | 0.291 Q3 | 30 | 57 | 66 | 2416 | 113 | 66 | 1.88 | 42.39 |
| Research and Reports in Urology | 0.285 Q2 | 20 | 20 | 63 | 572 | 34 | 62 | 0.48 | 28.6 |
| Nursing praxis in New Zealand inc | 0.255 Q3 | 14 | 9 | 37 | 0 | 19 | 29 | 0.25 | 0 |
| Transplant Research and Risk Management | 0.245 Q3 | 6 | 14 | 17 | 902 | 13 | 17 | 0.88 | 64.43 |
| Open Access Rheumatology: Research and Reviews | 0.240 Q3 | 14 | 11 | 30 | 720 | 22 | 30 | 0.64 | 65.45 |
| New Zealand Dental Journal | 0.236 Q3 | 21 | 25 | 76 | 350 | 35 | 51 | 0.31 | 14 |
| Lung Cancer: Targets and Therapy | 0.204 Q3 | 16 | 10 | 20 | 440 | 13 | 19 | 0.72 | 44 |
| Clinical Medicine Insights: Case Reports | 0.203 Q3 | 12 | 30 | 84 | 548 | 51 | 84 | 0.68 | 18.27 |
| Open Access Journal of Clinical Trials | 0.201 Q3 | 12 | 7 | 42 | 411 | 21 | 38 | 0.53 | 58.71 |
| Virus Adaptation and Treatment | 0.196 Q3 | 9 | 4 | 20 | 285 | 11 | 20 | 0.45 | 71.25 |
| Integrative Medicine Insights | 0.180 Q3 | 12 | 4 | 10 | 164 | 10 | 10 | 1 | 41 |
| Open Access Emergency Medicine | 0.174 Q3 | 14 | 3 | 34 | 118 | 10 | 34 | 0.23 | 39.33 |
| Clinical Medicine Insights: Gastroenterology | 0.158 Q3 | 11 | 8 | 20 | 449 | 7 | 20 | 0.5 | 56.13 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.154 Q3 | 20 | 19 | 77 | 0 | 17 | 72 | 0.21 | 0 |
| Clinical Medicine Insights: Therapeutics | 0.152 Q3 | 9 | 4 | 79 | 348 | 27 | 79 | 0.49 | 87 |
| Health Care and Informatics Review Online | 0.146 Q4 | 7 | 4 | 22 | 72 | 5 | 18 | 0.08 | 18 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.142 Q4 | 7 | 409 | 756 | 435 | 30 | 293 | 0.03 | 1.06 |
| Virology: Research and Treatment | 0.136 Q4 | 10 | 3 | 5 | 270 | 1 | 5 | 0.2 | 90 |
| International Medical Case Reports Journal | 0.133 Q4 | 11 | 35 | 59 | 626 | 23 | 59 | 0.46 | 17.89 |
| Reports in Medical Imaging | 0.129 Q4 | 8 | 10 | 21 | 480 | 3 | 19 | 0.13 | 48 |
| Reproductive Biology Insights | 0.119 Q4 | 5 | 3 | 5 | 203 | 2 | 5 | 0.5 | 67.67 |
| Immunology and Immunogenetics Insights | 0.108 Q4 | 6 | 2 | 3 | 78 | 0 | 3 | 0 | 39 |
| Perspectives in Medicinal Chemistry | 0.108 Q4 | 16 | 5 | 2 | 700 | 0 | 2 | 0 | 140 |
| Clinical Medicine Insights: Geriatrics | 0.106 Q4 | 2 | 0 | 4 | 0 | 0 | 4 | 0 | 0 |
| Palliative Care | 0.103 Q4 | 7 | 2 | 59 | 38 | 3 | 7 | 0 | 19 |
| Clinical Medicine Insights: Blood Disorders | 0.102 Q4 | 10 | 2 | 9 | 221 | 2 | 9 | 0.17 | 110.5 |
| New Zealand Public Health Surveillance Report | 0.102 Q4 | 1 | 3 | 34 | 22 | 0 | 10 | 0 | 7.33 |
| Adolescent Health, Medicine and Therapeutics | 3 | 1 | 0 | 70 | 0 | 0 | 0 | 70 | |
| Clinical Optometry | 7 | 9 | 0 | 223 | 0 | 0 | 0 | 24.78 | |
| Eye and Brain | 15 | 12 | 0 | 666 | 0 | 0 | 0 | 55.5 | |
| Journal of Blood Medicine | 18 | 6 | 0 | 444 | 0 | 0 | 0 | 74 | |
| Open Access Surgery | 1 | 1 | 0 | 34 | 0 | 0 | 0 | 34 | |
| Orthopedic Research and Reviews | 9 | 11 | 0 | 624 | 0 | 0 | 0 | 56.73 | |
| Psoriasis: Targets and Therapy | 4 | 3 | 0 | 297 | 0 | 0 | 0 | 99 | |
Daftar Jurnal Index Scopus Medicine 2013
| Title | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) |
| Clinical Epidemiology | 2.048 Q1 | 58 | 63 | 133 | 3020 | 421 | 120 | 2.84 | 47.94 |
| International Journal of Nanomedicine | 1.297 Q1 | 128 | 423 | 966 | 19083 | 4796 | 958 | 4.83 | 45.11 |
| International Journal of COPD | 1.269 Q1 | 67 | 88 | 214 | 2834 | 763 | 208 | 3.79 | 32.2 |
| Cancer Informatics | 0.871 Q2 | 31 | 18 | 67 | 841 | 97 | 62 | 1.54 | 46.72 |
| OncoTargets and Therapy | 0.850 Q2 | 60 | 199 | 92 | 9587 | 245 | 92 | 2.44 | 48.18 |
| Biomarker Insights | 0.793 Q2 | 31 | 15 | 52 | 604 | 141 | 52 | 2.39 | 40.27 |
| Clinical Ophthalmology | 0.786 Q2 | 56 | 348 | 828 | 8558 | 1387 | 821 | 1.65 | 24.59 |
| Vascular Health and Risk Management | 0.785 Q2 | 68 | 74 | 279 | 3262 | 782 | 275 | 2.75 | 44.08 |
| Cancer Management and Research | 0.778 Q2 | 40 | 43 | 110 | 2563 | 252 | 108 | 2.33 | 59.6 |
| Clinical Interventions in Aging | 0.773 Q2 | 76 | 199 | 155 | 8143 | 490 | 151 | 2.54 | 40.92 |
| Biologics: Targets and Therapy | 0.750 Q2 | 38 | 27 | 64 | 1865 | 196 | 62 | 3.23 | 69.07 |
| Neuropsychiatric Disease and Treatment | 0.719 Q2 | 67 | 209 | 192 | 10137 | 487 | 188 | 2.68 | 48.5 |
| International Journal of Women’s Health | 0.707 Q2 | 45 | 94 | 172 | 3431 | 381 | 170 | 1.95 | 36.5 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 0.701 Q2 | 43 | 51 | 71 | 2388 | 192 | 69 | 2.81 | 46.82 |
| Core Evidence (discontinued) | 0.685 Q1 | 23 | 7 | 29 | 442 | 82 | 28 | 3.63 | 63.14 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.676 Q2 | 21 | 10 | 31 | 326 | 69 | 31 | 2.05 | 32.6 |
| Clinical and Experimental Gastroenterology | 0.669 Q2 | 30 | 29 | 79 | 1074 | 159 | 78 | 2.3 | 37.03 |
| Journal of Inflammation Research | 0.652 Q3 | 33 | 15 | 45 | 590 | 100 | 45 | 2.6 | 39.33 |
| ClinicoEconomics and Outcomes Research | 0.651 Q2 | 27 | 57 | 78 | 2326 | 170 | 78 | 2.4 | 40.81 |
| Breast Cancer: Basic and Clinical Research | 0.637 Q3 | 23 | 6 | 48 | 217 | 103 | 47 | 1.82 | 36.17 |
| Application of Clinical Genetics | 0.636 Q3 | 32 | 13 | 31 | 893 | 28 | 30 | 1 | 68.69 |
| Patient Preference and Adherence | 0.636 Q2 | 48 | 119 | 195 | 4909 | 410 | 192 | 1.95 | 41.25 |
| Drug Target Insights | 0.614 Q2 | 12 | 6 | 6 | 212 | 11 | 6 | 1.83 | 35.33 |
| Cell Health and Cytoskeleton | 0.601 Q2 | 11 | 1 | 21 | 108 | 31 | 20 | 1.64 | 108 |
| Infection and Drug Resistance | 0.601 Q2 | 39 | 27 | 47 | 1454 | 121 | 46 | 2.73 | 53.85 |
| Clinical Medicine Insights: Oncology | 0.537 Q3 | 26 | 20 | 95 | 1240 | 187 | 95 | 2.07 | 62 |
| Journal of Pain Research | 0.491 Q2 | 49 | 76 | 116 | 3578 | 293 | 116 | 2.51 | 47.08 |
| Therapeutics and Clinical Risk Management | 0.478 Q2 | 55 | 57 | 71 | 2370 | 149 | 69 | 1.87 | 41.58 |
| HIV/AIDS – Research and Palliative Care | 0.462 Q2 | 22 | 31 | 50 | 1641 | 82 | 50 | 1.64 | 52.94 |
| Risk Management and Healthcare Policy | 0.420 Q2 | 22 | 9 | 38 | 168 | 58 | 35 | 1.61 | 18.67 |
| International Journal of General Medicine | 0.400 Q2 | 36 | 108 | 225 | 3484 | 332 | 222 | 1.36 | 32.26 |
| Journal of Asthma and Allergy | 0.399 Q3 | 30 | 14 | 41 | 541 | 74 | 40 | 2.1 | 38.64 |
| Clinical Pharmacology: Advances and Applications | 0.395 Q2 | 27 | 28 | 46 | 1197 | 66 | 43 | 2.06 | 42.75 |
| Integrated Blood Pressure Control | 0.395 Q2 | 20 | 14 | 8 | 832 | 19 | 8 | 2.67 | 59.43 |
| Clinical Medicine Insights: Cardiology | 0.394 Q3 | 21 | 15 | 59 | 642 | 66 | 58 | 1.17 | 42.8 |
| Neurobehavioral HIV Medicine | 0.368 Q3 | 9 | 2 | 13 | 150 | 13 | 13 | 1 | 75 |
| Drug, Healthcare and Patient Safety | 0.347 Q3 | 24 | 25 | 58 | 765 | 84 | 57 | 1.64 | 30.6 |
| Journal of Multidisciplinary Healthcare | 0.328 Q3 | 30 | 44 | 91 | 2146 | 119 | 91 | 1.2 | 48.77 |
| Substance Abuse: Research and Treatment | 0.328 Q3 | 22 | 18 | 22 | 836 | 18 | 21 | 0.76 | 46.44 |
| Fluoride – Quarterly Reports | 0.323 Q3 | 46 | 33 | 117 | 866 | 118 | 107 | 1.15 | 26.24 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.320 Q3 | 17 | 8 | 18 | 471 | 29 | 18 | 1.92 | 58.88 |
| International Journal of Interferon, Cytokine and Mediator Research | 0.316 Q3 | 11 | 3 | 32 | 268 | 31 | 32 | 1.12 | 89.33 |
| New Zealand Medical Journal | 0.310 Q3 | 50 | 386 | 1164 | 5093 | 629 | 799 | 0.49 | 13.19 |
| International Journal of Nephrology and Renovascular Disease | 0.287 Q3 | 27 | 36 | 62 | 1177 | 73 | 61 | 1.38 | 32.69 |
| Stem Cells and Cloning: Advances and Applications | 0.282 Q3 | 22 | 3 | 25 | 214 | 20 | 23 | 1 | 71.33 |
| Virus Adaptation and Treatment | 0.273 Q3 | 9 | 2 | 33 | 200 | 26 | 33 | 0.5 | 100 |
| Clinical, Cosmetic and Investigational Dermatology | 0.260 Q3 | 35 | 37 | 39 | 1346 | 45 | 38 | 1.06 | 36.38 |
| Psychology Research and Behavior Management | 0.253 Q3 | 30 | 16 | 46 | 917 | 42 | 44 | 0.97 | 57.31 |
| Local and Regional Anesthesia | 0.235 Q3 | 17 | 8 | 42 | 196 | 26 | 42 | 0.67 | 24.5 |
| Open Access Journal of Clinical Trials | 0.233 Q3 | 12 | 14 | 46 | 466 | 24 | 44 | 0.21 | 33.29 |
| Open Access Rheumatology: Research and Reviews | 0.225 Q3 | 14 | 9 | 28 | 544 | 13 | 27 | 0.48 | 60.44 |
| Nursing praxis in New Zealand inc | 0.193 Q3 | 14 | 12 | 36 | 0 | 15 | 29 | 0.32 | 0 |
| Lung Cancer: Targets and Therapy | 0.191 Q3 | 16 | 9 | 19 | 595 | 17 | 18 | 0.73 | 66.11 |
| New Zealand Dental Journal | 0.190 Q3 | 21 | 23 | 82 | 357 | 24 | 60 | 0.25 | 15.52 |
| Medical Devices: Evidence and Research | 0.189 Q3 | 30 | 27 | 47 | 829 | 43 | 47 | 0.82 | 30.7 |
| Open Access Emergency Medicine | 0.187 Q3 | 14 | 12 | 35 | 356 | 16 | 34 | 0.41 | 29.67 |
| Translational Oncogenomics | 0.187 Q3 | 10 | 0 | 2 | 0 | 1 | 2 | 1 | 0 |
| Clinical Medicine Insights: Case Reports | 0.170 Q3 | 12 | 38 | 59 | 624 | 24 | 59 | 0.37 | 16.42 |
| Immunology and Immunogenetics Insights | 0.169 Q4 | 6 | 1 | 5 | 29 | 2 | 5 | 0.5 | 29 |
| Reproductive Biology Insights | 0.167 Q3 | 5 | 2 | 4 | 108 | 1 | 4 | 0.33 | 54 |
| Breast Cancer: Targets and Therapy | 0.152 Q4 | 27 | 12 | 47 | 605 | 18 | 45 | 0.39 | 50.42 |
| Integrative Medicine Insights | 0.142 Q3 | 12 | 1 | 10 | 49 | 5 | 10 | 0.56 | 49 |
| Clinical Medicine Insights: Blood Disorders | 0.137 Q4 | 10 | 4 | 8 | 105 | 3 | 8 | 0.2 | 26.25 |
| Palliative Care | 0.135 Q4 | 7 | 6 | 53 | 194 | 6 | 1 | 0.11 | 32.33 |
| Journal of Experimental Pharmacology | 0.129 Q4 | 12 | 1 | 3 | 166 | 2 | 3 | 0.5 | 166 |
| Reports in Medical Imaging | 0.129 Q4 | 8 | 9 | 25 | 510 | 6 | 24 | 0.25 | 56.67 |
| Clinical Medicine Insights: Gastroenterology | 0.122 Q4 | 11 | 5 | 18 | 353 | 6 | 18 | 0.13 | 70.6 |
| Virology: Research and Treatment | 0.122 Q4 | 10 | 5 | 1 | 587 | 0 | 1 | 0 | 117.4 |
| Perspectives in Medicinal Chemistry | 0.121 Q4 | 16 | 0 | 5 | 0 | 2 | 5 | 0 | 0 |
| Clinical Medicine Insights: Therapeutics | 0.117 Q4 | 9 | 13 | 105 | 1049 | 30 | 105 | 0.32 | 80.69 |
| Transplant Research and Risk Management | 0.116 Q4 | 6 | 3 | 14 | 171 | 3 | 14 | 0.21 | 57 |
| Health Care and Informatics Review Online | 0.113 Q4 | 7 | 3 | 41 | 23 | 9 | 32 | 0.16 | 7.67 |
| Research and Reports in Urology | 0.113 Q4 | 20 | 31 | 53 | 1341 | 10 | 52 | 0.13 | 43.26 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.112 Q4 | 20 | 0 | 128 | 0 | 25 | 119 | 0.12 | 0 |
| Clinical Medicine Insights: Geriatrics | 0.111 Q4 | 2 | 2 | 2 | 282 | 0 | 2 | 0 | 141 |
| International Medical Case Reports Journal | 0.108 Q4 | 11 | 22 | 53 | 450 | 9 | 53 | 0.22 | 20.45 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.108 Q4 | 7 | 302 | 585 | 313 | 14 | 277 | 0.02 | 1.04 |
| New Zealand Public Health Surveillance Report | 0.101 Q4 | 1 | 0 | 46 | 0 | 0 | 20 | 0 | 0 |
Daftar Jurnal Index Scopus Medicine 2012
| Title | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) |
| International Journal of COPD | 1.145 Q1 | 67 | 85 | 172 | 2653 | 538 | 168 | 2.74 | 31.21 |
| International Journal of Nanomedicine | 1.041 Q1 | 128 | 519 | 480 | 22168 | 2062 | 480 | 4.11 | 42.71 |
| Clinical Epidemiology | 1.014 Q2 | 58 | 54 | 79 | 1646 | 228 | 74 | 2.89 | 30.48 |
| Biologics: Targets and Therapy | 0.845 Q2 | 38 | 46 | 67 | 3347 | 201 | 66 | 3.11 | 72.76 |
| Clinical Interventions in Aging | 0.836 Q1 | 76 | 68 | 137 | 2808 | 476 | 135 | 3.67 | 41.29 |
| Vascular Health and Risk Management | 0.806 Q2 | 68 | 73 | 316 | 3285 | 929 | 312 | 2.66 | 45 |
| OncoTargets and Therapy | 0.805 Q2 | 60 | 51 | 64 | 2641 | 151 | 64 | 3.1 | 51.78 |
| Breast Cancer: Basic and Clinical Research | 0.795 Q2 | 23 | 16 | 41 | 694 | 106 | 40 | 2.47 | 43.38 |
| Cancer Management and Research | 0.770 Q2 | 40 | 47 | 63 | 2398 | 160 | 63 | 2.54 | 51.02 |
| Core Evidence (discontinued) | 0.725 Q1 | 23 | 12 | 38 | 757 | 100 | 36 | 2.35 | 63.08 |
| Neuropsychiatric Disease and Treatment | 0.695 Q2 | 67 | 89 | 168 | 3755 | 405 | 147 | 2.22 | 42.19 |
| Clinical Ophthalmology | 0.662 Q2 | 56 | 316 | 614 | 7705 | 894 | 611 | 1.37 | 24.38 |
| Biomarker Insights | 0.648 Q2 | 31 | 16 | 44 | 759 | 108 | 44 | 2.47 | 47.44 |
| Infection and Drug Resistance | 0.614 Q2 | 39 | 20 | 33 | 953 | 61 | 31 | 2 | 47.65 |
| Patient Preference and Adherence | 0.590 Q2 | 48 | 94 | 141 | 3847 | 263 | 138 | 1.94 | 40.93 |
| International Journal of Women’s Health | 0.540 Q2 | 45 | 72 | 122 | 2921 | 260 | 119 | 2.21 | 40.57 |
| Therapeutics and Clinical Risk Management | 0.516 Q2 | 55 | 47 | 125 | 2311 | 268 | 125 | 2 | 49.17 |
| Journal of Pain Research | 0.478 Q2 | 49 | 62 | 69 | 2781 | 117 | 69 | 1.72 | 44.85 |
| Clinical Medicine Insights: Oncology | 0.452 Q3 | 26 | 44 | 61 | 2616 | 94 | 61 | 1.61 | 59.45 |
| HIV/AIDS – Research and Palliative Care | 0.452 Q2 | 22 | 21 | 29 | 806 | 40 | 29 | 1.38 | 38.38 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 0.447 Q2 | 43 | 42 | 51 | 2393 | 84 | 50 | 2.24 | 56.98 |
| Cancer Informatics | 0.387 Q3 | 31 | 15 | 78 | 514 | 85 | 74 | 1.19 | 34.27 |
| Journal of Inflammation Research | 0.382 Q3 | 33 | 17 | 28 | 664 | 37 | 28 | 1.32 | 39.06 |
| Perspectives in Medicinal Chemistry | 0.382 Q2 | 16 | 0 | 8 | 0 | 13 | 8 | 0.6 | 0 |
| International Journal of General Medicine | 0.379 Q2 | 36 | 136 | 124 | 4542 | 190 | 123 | 1.67 | 33.4 |
| Drug, Healthcare and Patient Safety | 0.375 Q2 | 24 | 17 | 51 | 826 | 64 | 49 | 1.22 | 48.59 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.360 Q3 | 21 | 10 | 25 | 422 | 38 | 25 | 1.76 | 42.2 |
| Clinical Medicine Insights: Cardiology | 0.357 Q3 | 21 | 20 | 51 | 662 | 51 | 50 | 0.95 | 33.1 |
| ClinicoEconomics and Outcomes Research | 0.353 Q2 | 27 | 44 | 44 | 1513 | 53 | 43 | 1.44 | 34.39 |
| Cell Health and Cytoskeleton | 0.347 Q3 | 11 | 10 | 11 | 1290 | 12 | 10 | 1.09 | 129 |
| New Zealand Medical Journal | 0.338 Q3 | 50 | 360 | 1149 | 5288 | 611 | 791 | 0.44 | 14.69 |
| Journal of Asthma and Allergy | 0.313 Q3 | 30 | 10 | 43 | 323 | 51 | 42 | 1.26 | 32.3 |
| Fluoride – Quarterly Reports | 0.288 Q3 | 46 | 45 | 114 | 1115 | 128 | 106 | 1 | 24.78 |
| International Journal of Nephrology and Renovascular Disease | 0.286 Q3 | 27 | 22 | 47 | 832 | 44 | 45 | 0.83 | 37.82 |
| Drug Target Insights | 0.283 Q3 | 12 | 4 | 3 | 209 | 3 | 3 | 0.5 | 52.25 |
| Open Access Emergency Medicine | 0.280 Q2 | 14 | 10 | 25 | 518 | 21 | 24 | 0.84 | 51.8 |
| Clinical, Cosmetic and Investigational Dermatology | 0.267 Q3 | 35 | 28 | 28 | 829 | 21 | 27 | 1.18 | 29.61 |
| Virus Adaptation and Treatment | 0.266 Q3 | 9 | 9 | 24 | 682 | 21 | 24 | 0.88 | 75.78 |
| Clinical and Experimental Gastroenterology | 0.264 Q3 | 30 | 23 | 56 | 985 | 70 | 56 | 1.25 | 42.83 |
| Clinical Medicine Insights: Gastroenterology | 0.259 Q3 | 11 | 9 | 9 | 301 | 6 | 9 | 0.67 | 33.44 |
| Nursing praxis in New Zealand inc | 0.257 Q3 | 14 | 12 | 40 | 0 | 16 | 32 | 0.29 | 0 |
| Clinical Pharmacology: Advances and Applications | 0.255 Q3 | 27 | 11 | 36 | 445 | 33 | 34 | 0.94 | 40.45 |
| Neurobehavioral HIV Medicine | 0.254 Q3 | 9 | 4 | 9 | 632 | 11 | 9 | 1.22 | 158 |
| Immunology and Immunogenetics Insights | 0.240 Q3 | 6 | 1 | 9 | 5 | 12 | 9 | 1.25 | 5 |
| Reports in Medical Imaging | 0.222 Q3 | 8 | 6 | 19 | 377 | 12 | 18 | 0.63 | 62.83 |
| International Journal of Interferon, Cytokine and Mediator Research | 0.220 Q4 | 11 | 7 | 25 | 775 | 23 | 25 | 0.92 | 110.71 |
| Application of Clinical Genetics | 0.218 Q4 | 32 | 13 | 20 | 981 | 18 | 20 | 1 | 75.46 |
| Psychology Research and Behavior Management | 0.213 Q3 | 30 | 23 | 34 | 812 | 30 | 34 | 1 | 35.3 |
| Breast Cancer: Targets and Therapy | 0.208 Q3 | 27 | 21 | 26 | 1159 | 15 | 25 | 0.58 | 55.19 |
| Substance Abuse: Research and Treatment | 0.185 Q3 | 22 | 12 | 22 | 715 | 16 | 21 | 0.5 | 59.58 |
| Journal of Multidisciplinary Healthcare | 0.181 Q3 | 30 | 38 | 61 | 1224 | 52 | 61 | 0.83 | 32.21 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.173 Q3 | 17 | 0 | 20 | 0 | 24 | 20 | 1.28 | 0 |
| Stem Cells and Cloning: Advances and Applications | 0.164 Q3 | 22 | 4 | 21 | 289 | 9 | 19 | 0.43 | 72.25 |
| Open Access Journal of Clinical Trials | 0.157 Q3 | 12 | 16 | 34 | 685 | 27 | 32 | 0.9 | 42.81 |
| Risk Management and Healthcare Policy | 0.156 Q4 | 22 | 16 | 22 | 469 | 8 | 21 | 0.36 | 29.31 |
| Medical Devices: Evidence and Research | 0.155 Q3 | 30 | 15 | 40 | 508 | 15 | 40 | 0.41 | 33.87 |
| New Zealand Dental Journal | 0.152 Q3 | 21 | 28 | 86 | 537 | 21 | 65 | 0.24 | 19.18 |
| Integrated Blood Pressure Control | 0.151 Q3 | 20 | 4 | 9 | 209 | 7 | 9 | 1.5 | 52.25 |
| Local and Regional Anesthesia | 0.143 Q3 | 17 | 7 | 35 | 197 | 17 | 35 | 0.49 | 28.14 |
| Open Access Rheumatology: Research and Reviews | 0.141 Q3 | 14 | 13 | 31 | 608 | 9 | 29 | 0.47 | 46.77 |
| Health Care and Informatics Review Online | 0.134 Q4 | 7 | 9 | 43 | 140 | 7 | 34 | 0.09 | 15.56 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.126 Q4 | 20 | 39 | 122 | 0 | 28 | 115 | 0.18 | 0 |
| Transplant Research and Risk Management | 0.125 Q4 | 6 | 5 | 9 | 223 | 4 | 9 | 0.44 | 44.6 |
| Journal of Experimental Pharmacology | 0.121 Q4 | 12 | 2 | 1 | 192 | 0 | 1 | 0 | 96 |
| Research and Reports in Urology | 0.121 Q4 | 20 | 11 | 42 | 439 | 9 | 41 | 0.21 | 39.91 |
| Translational Oncogenomics | 0.121 Q4 | 10 | 1 | 1 | 31 | 0 | 1 | 0 | 31 |
| Virology: Research and Treatment | 0.121 Q4 | 10 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| New Zealand Public Health Surveillance Report | 0.119 Q4 | 1 | 18 | 51 | 21 | 3 | 37 | 0 | 1.17 |
| Lung Cancer: Targets and Therapy | 0.116 Q4 | 16 | 9 | 10 | 746 | 3 | 9 | 0.3 | 82.89 |
| Clinical Medicine Insights: Geriatrics | 0.111 Q4 | 2 | 0 | 2 | 0 | 0 | 2 | 0 | 0 |
| Clinical Medicine Insights: Case Reports | 0.110 Q4 | 12 | 30 | 29 | 489 | 9 | 29 | 0.31 | 16.3 |
| Clinical Medicine Insights: Therapeutics | 0.109 Q4 | 9 | 22 | 83 | 1600 | 13 | 83 | 0.16 | 72.73 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.109 Q4 | 7 | 273 | 509 | 463 | 14 | 290 | 0.02 | 1.7 |
| Integrative Medicine Insights | 0.106 Q4 | 12 | 6 | 6 | 170 | 2 | 5 | 0.25 | 28.33 |
| Reproductive Biology Insights | 0.106 Q4 | 5 | 0 | 11 | 0 | 3 | 10 | 0.25 | 0 |
| Clinical Medicine Insights: Blood Disorders | 0.103 Q4 | 10 | 2 | 6 | 72 | 2 | 6 | 0.33 | 36 |
| International Medical Case Reports Journal | 0.103 Q4 | 11 | 19 | 34 | 314 | 3 | 34 | 0.09 | 16.53 |
| Clinical Medicine: Case Reports | 0.102 Q4 | 4 | 0 | 16 | 0 | 1 | 15 | 0 | 0 |
| Palliative Care | 7 | 1 | 52 | 17 | 6 | 0 | 0.12 | 17 | |
Daftar Jurnal Index Scopus Medicine 2011
| Title | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) |
| International Journal of COPD | 1.272 Q1 | 67 | 74 | 181 | 3080 | 551 | 176 | 2.96 | 41.62 |
| International Journal of Nanomedicine | 1.211 Q1 | 128 | 332 | 200 | 1277 | 906 | 198 | 2.97 | 3.85 |
| Vascular Health and Risk Management | 0.859 Q1 | 68 | 92 | 384 | 3863 | 1251 | 381 | 3.04 | 41.99 |
| Perspectives in Medicinal Chemistry | 0.785 Q2 | 16 | 2 | 13 | 81 | 36 | 13 | 4.5 | 40.5 |
| Clinical Epidemiology | 0.686 Q3 | 58 | 44 | 35 | 1657 | 66 | 34 | 1.89 | 37.66 |
| Clinical Interventions in Aging | 0.672 Q2 | 76 | 39 | 171 | 1592 | 545 | 169 | 3.09 | 40.82 |
| Neuropsychiatric Disease and Treatment | 0.652 Q2 | 67 | 82 | 212 | 4256 | 547 | 192 | 2.9 | 51.9 |
| Biologics: Targets and Therapy | 0.645 Q2 | 38 | 7 | 149 | 456 | 321 | 149 | 2.65 | 65.14 |
| OncoTargets and Therapy | 0.588 Q2 | 60 | 19 | 45 | 1125 | 90 | 45 | 2 | 59.21 |
| Cancer Informatics | 0.585 Q2 | 31 | 22 | 88 | 806 | 121 | 84 | 1.16 | 36.64 |
| Therapeutics and Clinical Risk Management | 0.540 Q2 | 55 | 7 | 264 | 273 | 620 | 263 | 2.67 | 39 |
| Biomarker Insights | 0.525 Q2 | 31 | 17 | 62 | 571 | 119 | 62 | 2.74 | 33.59 |
| Stem Cells and Cloning: Advances and Applications | 0.509 Q2 | 22 | 7 | 14 | 493 | 11 | 13 | 0.79 | 70.43 |
| Clinical Ophthalmology | 0.476 Q3 | 56 | 293 | 321 | 6826 | 427 | 319 | 1.33 | 23.3 |
| Patient Preference and Adherence | 0.454 Q2 | 48 | 71 | 120 | 2594 | 186 | 119 | 1.67 | 36.54 |
| Fluoride – Quarterly Reports | 0.367 Q3 | 46 | 34 | 138 | 791 | 125 | 131 | 0.8 | 23.26 |
| Cancer Management and Research | 0.324 Q3 | 40 | 31 | 32 | 1772 | 51 | 32 | 1.59 | 57.16 |
| Journal of Inflammation Research | 0.316 Q3 | 33 | 13 | 15 | 958 | 7 | 15 | 0.47 | 73.69 |
| New Zealand Medical Journal | 0.310 Q3 | 50 | 408 | 1145 | 5633 | 684 | 748 | 0.58 | 13.81 |
| International Journal of Women’s Health | 0.293 Q2 | 45 | 53 | 69 | 2175 | 104 | 68 | 1.51 | 41.04 |
| Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 0.271 Q3 | 21 | 11 | 14 | 365 | 14 | 14 | 1 | 33.18 |
| HIV/AIDS – Research and Palliative Care | 0.269 Q3 | 22 | 15 | 14 | 813 | 4 | 14 | 0.29 | 54.2 |
| Breast Cancer: Basic and Clinical Research | 0.263 Q3 | 23 | 23 | 18 | 1030 | 24 | 17 | 1.33 | 44.78 |
| Breast Cancer: Targets and Therapy | 0.254 Q3 | 27 | 17 | 9 | 825 | 7 | 9 | 0.78 | 48.53 |
| Clinical Medicine Insights: Oncology | 0.253 Q3 | 26 | 32 | 105 | 2304 | 66 | 102 | 1.55 | 72 |
| Journal of Pain Research | 0.250 Q2 | 49 | 44 | 25 | 1610 | 34 | 25 | 1.36 | 36.59 |
| International Journal of General Medicine | 0.247 Q3 | 36 | 35 | 89 | 1073 | 89 | 88 | 1 | 30.66 |
| Cell Health and Cytoskeleton | 0.241 Q3 | 11 | 4 | 7 | 218 | 4 | 7 | 0.57 | 54.5 |
| Core Evidence (discontinued) | 0.237 Q1 | 23 | 7 | 49 | 314 | 63 | 47 | 1.84 | 44.86 |
| Clinical Medicine Insights: Blood Disorders | 0.236 Q3 | 10 | 3 | 3 | 150 | 1 | 3 | 0.33 | 50 |
| Open Access Rheumatology: Research and Reviews | 0.225 Q3 | 14 | 8 | 23 | 594 | 11 | 21 | 0.48 | 74.25 |
| Nursing praxis in New Zealand inc | 0.209 Q3 | 14 | 13 | 43 | 0 | 12 | 33 | 0.19 | 0 |
| New Zealand Dental Journal | 0.204 Q3 | 21 | 25 | 86 | 430 | 31 | 66 | 0.33 | 17.2 |
| Virus Adaptation and Treatment | 0.188 Q3 | 9 | 9 | 15 | 956 | 9 | 15 | 0.6 | 106.22 |
| Journal of Asthma and Allergy | 0.184 Q3 | 30 | 11 | 38 | 520 | 20 | 38 | 0.47 | 47.27 |
| Integrated Blood Pressure Control | 0.175 Q3 | 20 | 2 | 7 | 162 | 3 | 7 | 0.43 | 81 |
| Open Access Journal of Clinical Trials | 0.172 Q3 | 12 | 12 | 22 | 266 | 19 | 22 | 0.86 | 22.17 |
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 0.168 Q3 | 43 | 15 | 36 | 640 | 27 | 35 | 0.75 | 42.67 |
| Risk Management and Healthcare Policy | 0.166 Q3 | 22 | 12 | 10 | 551 | 8 | 10 | 0.8 | 45.92 |
| Substance Abuse: Research and Treatment | 0.166 Q4 | 22 | 5 | 17 | 206 | 9 | 16 | 0.53 | 41.2 |
| Clinical, Cosmetic and Investigational Dermatology | 0.165 Q3 | 35 | 4 | 24 | 139 | 11 | 23 | 0.46 | 34.75 |
| Drug, Healthcare and Patient Safety | 0.165 Q4 | 24 | 16 | 35 | 598 | 21 | 33 | 0.6 | 37.38 |
| Clinical Medicine Insights: Cardiology | 0.164 Q3 | 21 | 16 | 35 | 530 | 11 | 34 | 0.31 | 33.13 |
| Drug Target Insights | 0.161 Q3 | 12 | 2 | 15 | 83 | 2 | 15 | 0 | 41.5 |
| Clinical and Experimental Gastroenterology | 0.157 Q3 | 30 | 31 | 25 | 2064 | 12 | 25 | 0.48 | 66.58 |
| Immunology and Immunogenetics Insights | 0.157 Q4 | 6 | 1 | 8 | 48 | 5 | 8 | 0.63 | 48 |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 0.153 Q3 | 17 | 13 | 7 | 598 | 5 | 7 | 0.71 | 46 |
| Application of Clinical Genetics | 0.151 Q4 | 32 | 13 | 10 | 1250 | 7 | 10 | 0.86 | 96.15 |
| Translational Oncogenomics | 0.147 Q3 | 10 | 0 | 11 | 0 | 4 | 11 | 1 | 0 |
| Reports in Medical Imaging | 0.141 Q4 | 8 | 6 | 13 | 232 | 3 | 13 | 0.23 | 38.67 |
| Integrative Medicine Insights | 0.135 Q3 | 12 | 3 | 8 | 61 | 7 | 7 | 0.67 | 20.33 |
| International Journal of Interferon, Cytokine and Mediator Research | 0.126 Q4 | 11 | 10 | 15 | 553 | 3 | 15 | 0.2 | 55.3 |
| Infection and Drug Resistance | 0.123 Q4 | 39 | 24 | 9 | 1292 | 2 | 8 | 0.22 | 53.83 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.123 Q4 | 20 | 38 | 84 | 0 | 20 | 79 | 0.24 | 0 |
| International Journal of Nephrology and Renovascular Disease | 0.122 Q4 | 27 | 18 | 29 | 923 | 6 | 28 | 0.21 | 51.28 |
| Journal of Experimental Pharmacology | 0.121 Q4 | 12 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Local and Regional Anesthesia | 0.121 Q4 | 17 | 11 | 24 | 309 | 7 | 24 | 0.29 | 28.09 |
| Virology: Research and Treatment | 0.121 Q4 | 10 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Psychology Research and Behavior Management | 0.118 Q4 | 30 | 14 | 23 | 742 | 8 | 23 | 0.35 | 53 |
| Journal of Multidisciplinary Healthcare | 0.117 Q4 | 30 | 45 | 32 | 1831 | 5 | 32 | 0.25 | 40.69 |
| Clinical Pharmacology: Advances and Applications | 0.116 Q4 | 27 | 7 | 29 | 132 | 6 | 28 | 0.21 | 18.86 |
| ClinicoEconomics and Outcomes Research | 0.115 Q4 | 27 | 18 | 26 | 749 | 7 | 25 | 0.27 | 41.61 |
| Health Care and Informatics Review Online | 0.114 Q4 | 7 | 10 | 58 | 165 | 11 | 46 | 0.12 | 16.5 |
| Clinical Medicine Insights: Therapeutics | 0.113 Q4 | 9 | 44 | 39 | 2873 | 9 | 39 | 0.23 | 65.3 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.113 Q4 | 7 | 181 | 492 | 0 | 26 | 291 | 0.05 | 0 |
| Medical Devices: Evidence and Research | 0.112 Q4 | 30 | 24 | 25 | 792 | 10 | 24 | 0.44 | 33 |
| Open Access Emergency Medicine | 0.111 Q4 | 14 | 12 | 13 | 500 | 4 | 12 | 0.31 | 41.67 |
| Clinical Medicine Insights: Gastroenterology | 0.107 Q4 | 11 | 6 | 3 | 216 | 0 | 3 | 0 | 36 |
| Research and Reports in Urology | 0.107 Q4 | 20 | 21 | 21 | 820 | 10 | 21 | 0.48 | 39.05 |
| Clinical Medicine Insights: Case Reports | 0.106 Q4 | 12 | 16 | 13 | 198 | 1 | 13 | 0.08 | 12.38 |
| Lung Cancer: Targets and Therapy | 0.103 Q4 | 16 | 2 | 8 | 50 | 1 | 8 | 0.13 | 25 |
| Reproductive Biology Insights | 0.103 Q4 | 5 | 3 | 10 | 137 | 0 | 7 | 0 | 45.67 |
| Clinical Medicine: Case Reports | 0.102 Q4 | 4 | 0 | 16 | 0 | 1 | 15 | 0.06 | 0 |
| International Medical Case Reports Journal | 0.101 Q4 | 11 | 18 | 16 | 355 | 0 | 16 | 0 | 19.72 |
| New Zealand Public Health Surveillance Report | 0.100 Q4 | 1 | 16 | 59 | 33 | 0 | 49 | 0 | 2.06 |
| Clinical Medicine Insights: Geriatrics | 2 | 2 | 0 | 152 | 0 | 0 | 0 | 76 | |
| Neurobehavioral HIV Medicine | 9 | 9 | 0 | 551 | 0 | 0 | 0 | 61.22 | |
| Transplant Research and Risk Management | 6 | 9 | 0 | 659 | 0 | 0 | 0 | 73.22 | |
Daftar Jurnal Index Scopus Medicine 2010
Daftar Jurnal Index Scopus Medicine 2009
Daftar Jurnal Index Scopus Medicine 2008
| Title | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) |
| Translational Oncogenomics | 0.925 Q2 | 10 | 10 | 1 | 1268 | 1 | 1 | 1 | 126.8 |
| International Journal of Nanomedicine | 0.580 Q2 | 128 | 52 | 106 | 2391 | 213 | 101 | 2.01 | 45.98 |
| Cancer Informatics | 0.491 Q3 | 31 | 32 | 82 | 1158 | 81 | 76 | 1 | 36.19 |
| Vascular Health and Risk Management | 0.423 Q2 | 68 | 160 | 214 | 9254 | 291 | 206 | 1.31 | 57.84 |
| New Zealand Medical Journal | 0.377 Q2 | 50 | 404 | 1373 | 4789 | 593 | 723 | 0.41 | 11.85 |
| Fluoride – Quarterly Reports | 0.280 Q3 | 46 | 58 | 128 | 953 | 133 | 123 | 1.06 | 16.43 |
| New Zealand Dental Journal | 0.268 Q3 | 21 | 25 | 62 | 573 | 16 | 38 | 0.23 | 22.92 |
| International Journal of COPD | 0.264 Q3 | 67 | 83 | 129 | 5086 | 97 | 119 | 0.75 | 61.28 |
| Clinical Interventions in Aging | 0.213 Q3 | 76 | 73 | 126 | 4471 | 103 | 121 | 0.82 | 61.25 |
| Therapeutics and Clinical Risk Management | 0.174 Q3 | 55 | 146 | 173 | 8343 | 100 | 162 | 0.58 | 57.14 |
| Neuropsychiatric Disease and Treatment | 0.155 Q4 | 67 | 126 | 174 | 8504 | 53 | 162 | 0.3 | 67.49 |
| Evidence-Based Integrative Medicine | 0.139 Q3 | 6 | 0 | 31 | 0 | 8 | 29 | 0 | 0 |
| Core Evidence (discontinued) | 0.120 Q1 | 23 | 18 | 30 | 1192 | 2 | 29 | 0 | 66.22 |
| Healthcare Review Online | 0.119 Q4 | 5 | 0 | 42 | 0 | 9 | 36 | 0.1 | 0 |
| Journal of the New Zealand Society of Periodontology | 0.118 Q4 | 5 | 0 | 8 | 0 | 1 | 7 | 0 | 0 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.108 Q4 | 20 | 0 | 143 | 0 | 12 | 129 | 0.09 | 0 |
| Patient Preference and Adherence | 0.107 Q4 | 48 | 50 | 19 | 1598 | 3 | 19 | 0.16 | 31.96 |
| Nursing praxis in New Zealand inc | 0.106 Q4 | 14 | 16 | 38 | 158 | 2 | 33 | 0 | 9.88 |
| Biologics: Targets and Therapy | 0.105 Q4 | 38 | 89 | 48 | 6093 | 8 | 45 | 0.17 | 68.46 |
| Health Care and Informatics Review Online | 0.102 Q4 | 7 | 25 | 30 | 329 | 1 | 20 | 0.03 | 13.16 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.102 Q4 | 7 | 164 | 507 | 133 | 6 | 291 | 0.01 | 0.81 |
| New Zealand Public Health Surveillance Report | 0.101 Q4 | 1 | 24 | 72 | 7 | 0 | 35 | 0 | 0.29 |
| Application of Clinical Genetics | 32 | 3 | 0 | 64 | 0 | 0 | 0 | 21.33 | |
| Biomarker Insights | 31 | 35 | 0 | 2221 | 0 | 0 | 0 | 63.46 | |
| Clinical Medicine Insights: Oncology | 26 | 76 | 0 | 2282 | 0 | 0 | 0 | 30.03 | |
| Drug Target Insights | 12 | 14 | 0 | 736 | 0 | 0 | 0 | 52.57 | |
| Integrative Medicine Insights | 12 | 5 | 0 | 299 | 0 | 0 | 0 | 59.8 | |
| Journal of Asthma and Allergy | 30 | 6 | 0 | 299 | 0 | 0 | 0 | 49.83 | |
| Journal of Multidisciplinary Healthcare | 30 | 16 | 0 | 339 | 0 | 0 | 0 | 21.19 | |
| Medical Devices: Evidence and Research | 30 | 9 | 0 | 179 | 0 | 0 | 0 | 19.89 | |
| Perspectives in Medicinal Chemistry | 16 | 7 | 0 | 666 | 0 | 0 | 0 | 95.14 | |
| Psychology Research and Behavior Management | 30 | 3 | 0 | 119 | 0 | 0 | 0 | 39.67 | |
Daftar Jurnal Index Scopus Medicine 2007
| Title | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2007) |
| Cancer Informatics | 0.445 Q3 | 31 | 51 | 31 | 1779 | 34 | 29 | 1.1 | 34.88 |
| New Zealand Medical Journal | 0.349 Q2 | 50 | 447 | 1322 | 4317 | 637 | 692 | 0.45 | 9.66 |
| International Journal of Nanomedicine | 0.282 Q2 | 128 | 47 | 59 | 2505 | 41 | 55 | 0.69 | 53.3 |
| International Journal of COPD | 0.276 Q2 | 67 | 76 | 53 | 4226 | 19 | 50 | 0.36 | 55.61 |
| New Zealand Dental Journal | 0.237 Q3 | 21 | 20 | 67 | 438 | 21 | 37 | 0.14 | 21.9 |
| Vascular Health and Risk Management | 0.224 Q3 | 68 | 114 | 100 | 6548 | 57 | 94 | 0.57 | 57.44 |
| Fluoride – Quarterly Reports | 0.216 Q3 | 46 | 33 | 130 | 755 | 138 | 124 | 1.08 | 22.88 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.171 Q3 | 20 | 65 | 143 | 11 | 34 | 134 | 0 | 0.17 |
| Neuropsychiatric Disease and Treatment | 0.148 Q4 | 67 | 105 | 69 | 6089 | 23 | 64 | 0.33 | 57.99 |
| Therapeutics and Clinical Risk Management | 0.148 Q3 | 55 | 126 | 47 | 6910 | 11 | 43 | 0.23 | 54.84 |
| Evidence-Based Integrative Medicine | 0.136 Q3 | 6 | 0 | 31 | 0 | 11 | 29 | 0.35 | 0 |
| Translational Oncogenomics | 0.122 Q4 | 10 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Clinical Interventions in Aging | 0.115 Q4 | 76 | 76 | 50 | 3449 | 6 | 48 | 0.12 | 45.38 |
| Nursing praxis in New Zealand inc | 0.112 Q4 | 14 | 10 | 28 | 32 | 2 | 25 | 0.07 | 3.2 |
| Core Evidence (discontinued) | 0.110 Q1 | 23 | 10 | 20 | 726 | 3 | 19 | 0.15 | 72.6 |
| Healthcare Review Online | 0.106 Q4 | 5 | 0 | 66 | 0 | 5 | 52 | 0.02 | 0 |
| Health Care and Informatics Review Online | 0.105 Q4 | 7 | 24 | 6 | 257 | 0 | 4 | 0 | 10.71 |
| Journal of the New Zealand Society of Periodontology | 0.104 Q4 | 5 | 4 | 7 | 52 | 2 | 7 | 0.5 | 13 |
| New Zealand Public Health Surveillance Report | 0.101 Q4 | 1 | 24 | 72 | 30 | 0 | 15 | 0 | 1.25 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.100 Q4 | 7 | 126 | 525 | 225 | 5 | 294 | 0.01 | 1.79 |
| Biologics: Targets and Therapy | 38 | 48 | 0 | 3348 | 0 | 0 | 0 | 69.75 | |
| Patient Preference and Adherence | 48 | 19 | 0 | 599 | 0 | 0 | 0 | 31.53 | |
Daftar Jurnal Index Scopus Medicine 2006
| Title | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) |
| New Zealand Medical Journal | 0.380 Q2 | 50 | 460 | 1230 | 4399 | 584 | 640 | 0.46 | 9.56 |
| Fluoride – Quarterly Reports | 0.307 Q3 | 46 | 52 | 108 | 1134 | 132 | 101 | 1.08 | 21.81 |
| Journal of the New Zealand Society of Periodontology | 0.297 Q2 | 5 | 3 | 4 | 0 | 5 | 4 | 1.25 | 0 |
| New Zealand Dental Journal | 0.270 Q2 | 21 | 20 | 70 | 170 | 27 | 38 | 0.32 | 8.5 |
| Cancer Informatics | 0.259 Q3 | 31 | 30 | 1 | 1164 | 0 | 1 | 0 | 38.8 |
| Vascular Health and Risk Management | 0.143 Q3 | 68 | 56 | 44 | 3527 | 14 | 41 | 0.32 | 62.98 |
| Eubios journal of Asian and international bioethics : EJAIB. | 0.120 Q3 | 4 | 0 | 11 | 0 | 1 | 10 | 0 | 0 |
| Healthcare Review Online | 0.114 Q4 | 5 | 21 | 51 | 341 | 7 | 39 | 0.16 | 16.24 |
| Evidence-Based Integrative Medicine | 0.112 Q4 | 6 | 0 | 31 | 0 | 4 | 29 | 0.13 | 0 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.109 Q4 | 20 | 24 | 165 | 79 | 15 | 154 | 0.11 | 3.29 |
| New Zealand Public Health Surveillance Report | 0.104 Q4 | 1 | 24 | 54 | 29 | 0 | 5 | 0 | 1.21 |
| Core Evidence (discontinued) | 0.102 Q1 | 23 | 8 | 12 | 596 | 0 | 11 | 0 | 74.5 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.102 Q4 | 7 | 230 | 448 | 86 | 5 | 295 | 0.01 | 0.37 |
| Nursing praxis in New Zealand inc | 0.101 Q4 | 14 | 11 | 17 | 100 | 1 | 15 | 0.06 | 9.09 |
| Clinical Interventions in Aging | 76 | 50 | 0 | 2086 | 0 | 0 | 0 | 41.72 | |
| Health Care and Informatics Review Online | 7 | 6 | 0 | 73 | 0 | 0 | 0 | 12.17 | |
| International Journal of COPD | 67 | 53 | 0 | 2498 | 0 | 0 | 0 | 47.13 | |
| International Journal of Nanomedicine | 128 | 59 | 0 | 2705 | 0 | 0 | 0 | 45.85 | |
| Neuropsychiatric Disease and Treatment | 67 | 69 | 0 | 3465 | 0 | 0 | 0 | 50.22 | |
| Therapeutics and Clinical Risk Management | 55 | 47 | 0 | 2919 | 0 | 0 | 0 | 62.11 | |
| Translational Oncogenomics | 10 | 1 | 0 | 79 | 0 | 0 | 0 | 79 | |
Daftar Jurnal Index Scopus Medicine 2005
| Title | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) |
| New Zealand Medical Journal | 0.348 Q2 | 50 | 466 | 1107 | 5143 | 478 | 570 | 0.39 | 11.04 |
| Fluoride – Quarterly Reports | 0.205 Q3 | 46 | 43 | 89 | 853 | 69 | 81 | 0.72 | 19.84 |
| New Zealand Dental Journal | 0.174 Q3 | 21 | 22 | 59 | 389 | 14 | 36 | 0.17 | 17.68 |
| Nursing praxis in New Zealand inc | 0.123 Q3 | 14 | 17 | 19 | 0 | 1 | 16 | 0 | 0 |
| Journal of Pain Research | 0.122 Q3 | 49 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.118 Q3 | 20 | 54 | 169 | 0 | 16 | 161 | 0.04 | 0 |
| Healthcare Review Online | 0.112 Q4 | 5 | 21 | 56 | 292 | 3 | 44 | 0.07 | 13.9 |
| Journal of the New Zealand Society of Periodontology | 0.111 Q4 | 5 | 1 | 3 | 0 | 3 | 3 | 1 | 0 |
| New Zealand Public Health Report | 0.104 Q4 | 10 | 0 | 10 | 0 | 2 | 5 | 0 | 0 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.104 Q4 | 7 | 151 | 404 | 40 | 6 | 285 | 0.01 | 0.26 |
| Eubios journal of Asian and international bioethics : EJAIB. | 0.102 Q4 | 4 | 0 | 11 | 0 | 2 | 10 | 0.18 | 0 |
| Cancer Informatics | 31 | 1 | 0 | 8 | 0 | 0 | 0 | 8 | |
| Core Evidence (discontinued) | 23 | 12 | 0 | 708 | 0 | 0 | 0 | 59 | |
| Evidence-Based Integrative Medicine | 6 | 31 | 0 | 1385 | 0 | 0 | 0 | 44.68 | |
| New Zealand Public Health Surveillance Report | 1 | 24 | 30 | 19 | 0 | 0 | 0 | 0.79 | |
| Vascular Health and Risk Management | 68 | 44 | 0 | 2132 | 0 | 0 | 0 | 48.45 | |
Daftar Jurnal Index Scopus Medicine 2004
| Title | SJR | H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2004) |
| New Zealand Medical Journal | 0.366 Q2 | 50 | 396 | 1037 | 4332 | 485 | 538 | 0.45 | 10.94 |
| Fluoride – Quarterly Reports | 0.227 Q3 | 46 | 35 | 80 | 1017 | 92 | 71 | 1 | 29.06 |
| New Zealand Dental Journal | 0.206 Q2 | 21 | 25 | 57 | 414 | 19 | 43 | 0.35 | 16.56 |
| Nursing praxis in New Zealand inc | 0.165 Q3 | 14 | 0 | 19 | 0 | 3 | 16 | 0.16 | 0 |
| New Zealand Public Health Report | 0.146 Q4 | 10 | 0 | 44 | 0 | 8 | 19 | 0.1 | 0 |
| Journal of Pain Research | 0.121 Q3 | 49 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.113 Q3 | 20 | 65 | 169 | 232 | 14 | 158 | 0.05 | 3.57 |
| Journal of the New Zealand Society of Periodontology | 0.111 Q4 | 5 | 3 | 2 | 112 | 0 | 2 | 0 | 37.33 |
| Healthcare Review Online | 0.104 Q4 | 5 | 24 | 51 | 166 | 2 | 41 | 0.03 | 6.92 |
| Eubios journal of Asian and international bioethics : EJAIB. | 0.102 Q4 | 4 | 0 | 11 | 0 | 1 | 10 | 0.09 | 0 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.102 Q4 | 7 | 144 | 434 | 169 | 7 | 308 | 0.02 | 1.17 |
Daftar Jurnal Index Scopus Medicine 2003
| Title | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) |
| New Zealand Medical Journal | 0.340 Q2 | 50 | 368 | 945 | 2943 | 366 | 511 | 0.33 | 8 |
| Fluoride – Quarterly Reports | 0.288 Q2 | 46 | 30 | 79 | 588 | 65 | 69 | 1 | 19.6 |
| New Zealand Dental Journal | 0.161 Q3 | 21 | 23 | 64 | 398 | 19 | 57 | 0.44 | 17.3 |
| Journal of the New Zealand Society of Periodontology | 0.154 Q3 | 5 | 0 | 6 | 0 | 2 | 5 | 0 | 0 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.129 Q3 | 20 | 46 | 173 | 131 | 17 | 161 | 0.06 | 2.85 |
| Nursing praxis in New Zealand inc | 0.128 Q3 | 14 | 0 | 32 | 0 | 5 | 29 | 0.16 | 0 |
| Journal of Pain Research | 0.121 Q3 | 49 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Eubios journal of Asian and international bioethics : EJAIB. | 0.107 Q4 | 4 | 11 | 3 | 0 | 1 | 3 | 0 | 0 |
| New Zealand Public Health Report | 0.102 Q4 | 10 | 0 | 63 | 0 | 7 | 38 | 0.14 | 0 |
| Healthcare Review Online | 0.101 Q4 | 5 | 6 | 86 | 18 | 3 | 71 | 0.02 | 3 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.100 Q4 | 7 | 153 | 419 | 140 | 1 | 302 | 0 | 0.92 |
Daftar Jurnal Index Scopus Medicine 2002
| Title | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2002) |
| New Zealand Medical Journal | 0.324 Q2 | 50 | 343 | 875 | 3247 | 402 | 498 | 0.46 | 9.47 |
| Fluoride – Quarterly Reports | 0.256 Q3 | 46 | 24 | 82 | 513 | 52 | 70 | 0.69 | 21.38 |
| Eubios journal of Asian and international bioethics : EJAIB. | 0.236 Q2 | 4 | 0 | 3 | 0 | 1 | 3 | 0.33 | 0 |
| New Zealand Public Health Report | 0.183 Q3 | 10 | 10 | 71 | 121 | 15 | 48 | 0.19 | 12.1 |
| New Zealand Dental Journal | 0.168 Q2 | 21 | 11 | 80 | 34 | 21 | 65 | 0.13 | 3.09 |
| Healthcare Review Online | 0.118 Q3 | 5 | 26 | 101 | 134 | 3 | 78 | 0.03 | 5.15 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.115 Q3 | 20 | 58 | 115 | 63 | 10 | 107 | 0.09 | 1.09 |
| Journal of the New Zealand Society of Periodontology | 0.102 Q4 | 5 | 0 | 11 | 0 | 0 | 10 | 0 | 0 |
| Nursing praxis in New Zealand inc | 0.102 Q4 | 14 | 19 | 32 | 185 | 2 | 31 | 0.08 | 9.74 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.101 Q4 | 7 | 107 | 403 | 178 | 3 | 306 | 0.01 | 1.66 |
| Journal of Pain Research | 49 | 1 | 0 | 28 | 0 | 0 | 0 | 28 | |
Daftar Jurnal Index Scopus Medicine 2001
| Title | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) |
| New Zealand Medical Journal | 0.313 Q2 | 50 | 326 | 798 | 2803 | 366 | 476 | 0.37 | 8.6 |
| New Zealand Public Health Report | 0.271 Q2 | 10 | 34 | 63 | 249 | 22 | 45 | 0.46 | 7.32 |
| Fluoride – Quarterly Reports | 0.231 Q3 | 46 | 26 | 92 | 531 | 46 | 72 | 0.46 | 20.42 |
| New Zealand Dental Journal | 0.137 Q3 | 21 | 23 | 97 | 192 | 12 | 79 | 0.14 | 8.35 |
| Healthcare Review Online | 0.125 Q3 | 5 | 19 | 126 | 106 | 4 | 100 | 0.01 | 5.58 |
| Eubios journal of Asian and international bioethics : EJAIB. | 0.107 Q3 | 4 | 0 | 3 | 0 | 0 | 3 | 0 | 0 |
| Journal of the New Zealand Society of Periodontology | 0.102 Q4 | 5 | 2 | 14 | 31 | 0 | 12 | 0 | 15.5 |
| Nursing praxis in New Zealand inc | 0.102 Q4 | 14 | 0 | 52 | 0 | 1 | 48 | 0 | 0 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 0.101 Q4 | 20 | 65 | 50 | 397 | 1 | 46 | 0.02 | 6.11 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.100 Q4 | 7 | 174 | 320 | 154 | 1 | 273 | 0 | 0.89 |
| Neuropsychiatric Disease and Treatment | 67 | 1 | 0 | 15 | 0 | 0 | 0 | 15 | |
Daftar Jurnal Index Scopus Medicine 2000
| Title | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) |
| New Zealand Public Health Report | 0.406 Q2 | 10 | 19 | 58 | 176 | 35 | 40 | 0.59 | 9.26 |
| New Zealand Medical Journal | 0.324 Q2 | 50 | 276 | 788 | 2657 | 350 | 477 | 0.41 | 9.63 |
| Fluoride – Quarterly Reports | 0.211 Q3 | 46 | 29 | 90 | 470 | 25 | 73 | 0.21 | 16.21 |
| New Zealand Dental Journal | 0.186 Q2 | 21 | 30 | 91 | 92 | 15 | 70 | 0.16 | 3.07 |
| Eubios journal of Asian and international bioethics : EJAIB. | 0.121 Q3 | 4 | 3 | 1 | 0 | 0 | 1 | 0 | 0 |
| Nursing praxis in New Zealand inc | 0.115 Q3 | 14 | 13 | 59 | 109 | 3 | 51 | 0.03 | 8.38 |
| Healthcare Review Online | 0.109 Q3 | 5 | 41 | 107 | 234 | 1 | 82 | 0.01 | 5.71 |
| Journal of the New Zealand Society of Periodontology | 0.101 Q4 | 5 | 4 | 21 | 23 | 1 | 20 | 0.1 | 5.75 |
| New Zealand health & hospital | 0.101 Q4 | 1 | 0 | 29 | 0 | 0 | 28 | 0 | 0 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.100 Q4 | 7 | 138 | 286 | 33 | 1 | 266 | 0 | 0.24 |
| Pacific health dialog : a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine | 20 | 50 | 0 | 70 | 0 | 0 | 0 | 1.4 | |
Daftar Jurnal Index Scopus Medicine 1999
| Title | SJR | H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) |
| New Zealand Medical Journal | 0.315 Q2 | 50 | 273 | 805 | 2668 | 314 | 489 | 0.34 | 9.77 |
| Fluoride – Quarterly Reports | 0.215 Q3 | 46 | 27 | 125 | 444 | 31 | 113 | 0.32 | 16.44 |
| New Zealand Public Health Report | 0.184 Q3 | 10 | 18 | 40 | 294 | 12 | 25 | 0.3 | 16.33 |
| Eubios journal of Asian and international bioethics : EJAIB. | 0.121 Q3 | 4 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| New Zealand Dental Journal | 0.113 Q3 | 21 | 27 | 84 | 112 | 5 | 67 | 0.05 | 4.15 |
| Nursing praxis in New Zealand inc | 0.106 Q3 | 14 | 19 | 73 | 141 | 2 | 63 | 0.05 | 7.42 |
| Journal of the New Zealand Society of Periodontology | 0.101 Q4 | 5 | 5 | 19 | 44 | 0 | 18 | 0 | 8.8 |
| Nursing New Zealand (Wellington, N.Z. : 1995) | 0.101 Q4 | 7 | 91 | 294 | 90 | 4 | 275 | 0.01 | 0.99 |
| Healthcare Review Online | 0.100 Q4 | 5 | 41 | 79 | 297 | 0 | 64 | 0 | 7.24 |
| New Zealand health & hospital | 0.100 Q4 | 1 | 0 | 58 | 0 | 0 | 57 | 0 | 0 |
Apakah referensi yang Anda cari tersedia? Yakin yang dicari jurnal sjr scopus Medicine New Zealand ? atau Anda ingin mencari jasa pembuatan jurnal scopus? Silakan menghubungi admin ruang jurnal, untuk pemesanan paket pembuatan jurnal dan konversi jurnal, baik jurnal scopus maupun sinta.










